{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "MSEPO-21204 MSE Intravenous IV Medicines Policy.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 16,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "PERIPHERAL INTRAVENOUS (IV) MEDICINES ADMINISTRATION POLICY"
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "MSEPO-21204"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP/CCP)"
                    },
                    {
                        "text": "Policy"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "All staff involved in the preparation and/or administration of intravenous medicines"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "30 November 2021"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "29 November 2024"
                    },
                    {
                        "text": "Key word(s) to search for document on intranet:"
                    },
                    {
                        "text": "Intravenous, IV, IVAB, flushing, administration, medicines, medication, medusa, bolus, infusion"
                    },
                    {
                        "text": "Developed in response to: (National Guidance/Recommen dations (i.e. NICE; RCOG)"
                    },
                    {
                        "text": "NPSA (2007) PSA 20: Promoting Safer Use of Injectable Medicines. RPS/RCN (2019) Professional Guidance on the Administration of Medicines in Healthcare Settings. SPS (2021) Using gravity infusions and bolus injections in adults NIVAS (2021) Intravenous Administration of Medicines to adults: Guidance on \u201cline flushing\u201d"
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "12"
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "Division 9 - Pharmacy"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Richard Ketley"
                    },
                    {
                        "text": "Principal Pharmacist Medication Safety & MSO"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box(s) to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "\u2612 MSE NHS Foundation Trust \u2610 Basildon Hospital \u2610 Broomfield Hospital \u2610 Southend Hospital \u2610 Other (please state)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "Medicines Assurance Group Chair action: A Kabir"
                    },
                    {
                        "text": "24 November 2021"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Evelyn Allen"
                    },
                    {
                        "text": "Chief Pharmacist"
                    },
                    {
                        "text": "24 November 2021"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Joint Document Management Group"
                    },
                    {
                        "text": "30 November 2021"
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Joint Document Management Group)"
                    },
                    {
                        "text": "December 21"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "\u2612 Trust Intranet"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 3,
            "data": {
                "url": "MSEPO-21204 MSE Intravenous IV Medicines Policy.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 18,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Consulted With: (Must include Specialist Pharmacists if the document has any reference to medication)"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Simon Worrall"
                    },
                    {
                        "text": "Deputy Chief Pharmacist"
                    },
                    {
                        "text": "12 October 2021"
                    },
                    {
                        "text": "Tomi Tommy-Uffang"
                    },
                    {
                        "text": "Head of Department Pharmacy, Southend"
                    },
                    {
                        "text": "12 October 2021"
                    },
                    {
                        "text": "Fatemeh Leedham"
                    },
                    {
                        "text": "Head of Department Pharmacy, Basildon"
                    },
                    {
                        "text": "12 October 2021"
                    },
                    {
                        "text": "Alison Felton"
                    },
                    {
                        "text": "Head of Department Pharmacy, Broomfield"
                    },
                    {
                        "text": "12 October 2021"
                    },
                    {
                        "text": "Anna Man"
                    },
                    {
                        "text": "Principal Pharmacist, Basildon"
                    },
                    {
                        "text": "12 October 2021"
                    },
                    {
                        "text": "Helen Ellis"
                    },
                    {
                        "text": "Principal Pharmacist, Broomfield"
                    },
                    {
                        "text": "12 October 2021"
                    },
                    {
                        "text": "Maria Richards"
                    },
                    {
                        "text": "Principal Pharmacist, Emergency Care"
                    },
                    {
                        "text": "12 October 2021"
                    },
                    {
                        "text": "Paul Smith"
                    },
                    {
                        "text": "Principal Pharmacist, Surgery, Theatres & Anaesthetics, Trauma & Orthopaedics"
                    },
                    {
                        "text": "12 October 2021"
                    },
                    {
                        "text": "Andrea Burzio"
                    },
                    {
                        "text": "Simulation lead, Basildon"
                    },
                    {
                        "text": "12 October 2021"
                    },
                    {
                        "text": "Michelle Asba"
                    },
                    {
                        "text": "Practice Development Nurse, Southend"
                    },
                    {
                        "text": "05 October 2021"
                    },
                    {
                        "text": "Simi Ncube-kaseke"
                    },
                    {
                        "text": "Practice Development Nurse, Southend"
                    },
                    {
                        "text": "07 October 2021"
                    },
                    {
                        "text": "Sue Poole"
                    },
                    {
                        "text": "Practice Development Nurse, Broomfield"
                    },
                    {
                        "text": "07 October 2021"
                    },
                    {
                        "text": "Diane Sarker"
                    },
                    {
                        "text": "Chief Nursing Officer"
                    },
                    {
                        "text": "12 October 2021"
                    },
                    {
                        "text": "Kelly McGovern"
                    },
                    {
                        "text": "Director of Nursing Broomfield/CG2"
                    },
                    {
                        "text": "12 October 2021"
                    },
                    {
                        "text": "Dawn Patience"
                    },
                    {
                        "text": "Director of Nursing Basildon/CG1"
                    },
                    {
                        "text": "12 October 2021"
                    },
                    {
                        "text": "Yvonne Brierley"
                    },
                    {
                        "text": "Acting Director of Nursing Southend/CG3"
                    },
                    {
                        "text": "12 October 2021"
                    },
                    {
                        "text": "Lucy Chaplin"
                    },
                    {
                        "text": "Practice Education Facilitator Nurse Medicine, Basildon"
                    },
                    {
                        "text": "22 November 2021"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 2,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Post/ Approval Committee/ Group: (Must include Medication Assurance Group if the document has any reference to medication)"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Medicines Assurance Group (as page 1)"
                    },
                    {
                        "text": "24 November 2021"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 2,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "Safe handling of medicines policy (or equivalent) MSEPO-20205 Policy for safe and secure storage of medicines MSEPO-21128 Administration of medicines policy MSEPO-21002 Patient identification policy and procedure MSEPO-20215 Hand Hygiene MSEPO-21024 Aseptic non touch technique (ANTT) MSEPO-21052 Management of needlestick sharps and splash injuries for staff MSEPO-21112 Waste Management Policy and Procedure MSEGL-21001 IV Infusions: mls per hour vs. drops per minute Trust Extravasation guidelines (or equivalent) Trust Cannulation insertion and care policy (or equivalent) Trust Policy and procedures for the management of central venous access devices in adults (or equivalent)."
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 7,
            "data": {
                "num_rows": 5,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/ Reviewer:"
                    },
                    {
                        "text": "Summary of amendments/ Record documents superseded by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Richard Ketley"
                    },
                    {
                        "text": "30 November 2021"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Intravenous medication reconstitution and administration and sections 4.4.1 (flushing section only), 4.4.3, 4.5 and 4.6 of"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 8,
            "data": {
                "num_rows": 1,
                "num_cols": 4,
                "table_items": [
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "CP/PO/00011 Peripheral Intravenous Management Policies."
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Contents"
            },
            "type": "ListItem",
            "sequence_num": 9
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "Introduction ................................................................................................................... 6"
            },
            "type": "ListItem",
            "sequence_num": 10
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.0,
                "text": "Scope ........................................................................................................................... 6"
            },
            "type": "ListItem",
            "sequence_num": 11
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 3.0,
                "text": "Definitions ..................................................................................................................... 6"
            },
            "type": "ListItem",
            "sequence_num": 12
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.0,
                "text": "Role & responsibilities within the Trust ......................................................................... 7"
            },
            "type": "ListItem",
            "sequence_num": 13
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.0,
                "text": "Authority to prepare and administer IV medication ..................................................... 10"
            },
            "type": "ListItem",
            "sequence_num": 14
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.0,
                "text": "Requirements for single and second-independent checks in adults ........................... 12"
            },
            "type": "ListItem",
            "sequence_num": 15
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.0,
                "text": "Infection control & waste management ....................................................................... 13"
            },
            "type": "ListItem",
            "sequence_num": 16
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.0,
                "text": "Requirements before preparation ............................................................................... 14"
            },
            "type": "ListItem",
            "sequence_num": 17
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 25.0,
                "text": "Preparing IV medicines - general principles ............................................................... 15  Maximum fill additions to infusion bags prepared in clinical areas .............................. 16  Labelling ..................................................................................................................... 18  Administering IV medicines\u2013 general principles ......................................................... 19  Administration Sets ..................................................................................................... 21  Flushing peripheral cannulae ...................................................................................... 22  Flushing after small volume intravenous infusions ..................................................... 24  Using an infusion pump .............................................................................................. 25  Gravity infusions ......................................................................................................... 25  Monitoring of the patient ............................................................................................. 26  Extravasation .............................................................................................................. 26  Anaphylaxis ................................................................................................................ 27  Training requirements ................................................................................................. 27  Monitoring and audit ................................................................................................... 28  Approval and implementation ..................................................................................... 28  Equality impact assessment ....................................................................................... 28  References ................................................................................................................. 29Appendix 1: Procedure for reconstitution of an injection .................................................... 31 Appendix 2: Procedure for adding medication to an IV infusion ......................................... 33 Appendix 3: Procedure for administration of IV INFUSION via a PERIPHERAL cannula .. 35 Appendix 4: Procedure for administration of an IV BOLUS injection ................................. 38 Appendix 5: Gravity infusion calculations ........................................................................... 40 Appendix 6: Preliminary Equality Analysis ......................................................................... 41"
            },
            "type": "ListItem",
            "sequence_num": 18
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Introduction"
            },
            "type": "ListItem",
            "sequence_num": 19
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.1,
                "text": "Preparation and administration of intravenous (IV) medicines can be complex and this means a great potential risk to the patient compared to other routes of administration."
            },
            "type": "ListItem",
            "sequence_num": 20
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.2,
                "text": "Intravenous medicines should be prescribed, prepared, administered and monitored only by healthcare staff that understand the risks involved, have been trained to use safe procedures, and have demonstrated their competence for the task."
            },
            "type": "ListItem",
            "sequence_num": 21
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.3,
                "text": "This policy incorporates best practice in line with national guidance."
            },
            "type": "ListItem",
            "sequence_num": 22
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Scope"
            },
            "type": "ListItem",
            "sequence_num": 23
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.1,
                "text": "The purpose of this document is to set out a framework of which eliminates or reduces the risk of patient harm when preparing and administering IV medication. In doing so this upholds the principles of the NPSA patient safety alert 20: Promoting the Safer Use of Injectable Medicines."
            },
            "type": "ListItem",
            "sequence_num": 24
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.2,
                "text": "This policy only covers processes related to IV medicines administration via a peripheral cannula. For medicines via a central venous access device refer to Policy and Procedures for the Management of Central Venous Access Devices (in Adults), or equivalent."
            },
            "type": "ListItem",
            "sequence_num": 25
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.3,
                "text": "This is a medication policy and therefore staff should refer to associate policies for information related to cannula and device management (i.e. Peripheral intravenous cannula & device management policy, or equivalent), and for blood products."
            },
            "type": "ListItem",
            "sequence_num": 26
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.4,
                "text": "This policy does not apply to cytotoxic agents or agents being used in the treatment of malignant disease. Please refer to the Trust Cytotoxic/ Chemotherapy Medicines Policy (or equivalent)."
            },
            "type": "ListItem",
            "sequence_num": 27
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.5,
                "text": "Some variation in the techniques described may be required in specialist areas i.e. theatres / critical care. In this instance it is the responsibility of the practitioner to ensure effective infection control principles are maintained and any variations are clinically justified, safe and approved within the clinical specialty."
            },
            "type": "ListItem",
            "sequence_num": 28
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Definitions"
            },
            "type": "ListItem",
            "sequence_num": 29
        },
        {
            "type": "table",
            "sequence_num": 30,
            "data": {
                "num_rows": 4,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "TERM"
                    },
                    {
                        "text": "DEFINITION"
                    },
                    {
                        "text": "AHP"
                    },
                    {
                        "text": "Allied Health Professional"
                    },
                    {
                        "text": "ANTT"
                    },
                    {
                        "text": "Aseptic Non- Touch Technique, a method of preventing contamination through the protection of key parts that are sterile, or have been decontaminated."
                    },
                    {
                        "text": "Blunt fill needle"
                    },
                    {
                        "text": "Drawing up needle, large bore, safety device with 45\u00b0 tip to reduce risk of coring. Suitable for drawing up from plastic ampoules and accessing vials with an injectable top."
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 31,
            "data": {
                "num_rows": 13,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Blunt fill filter needle"
                    },
                    {
                        "text": "Drawing up needle, large bore, safety device with 45\u00b0 tip to reduce risk of coring, includes a filter to prevent aspiration of glass particles into the syringe when using glass ampoules. The needle must be changed prior to injecting the contents into"
                    },
                    {
                        "text": "an infusion bag"
                    },
                    {
                        "text": "CVC"
                    },
                    {
                        "text": "Central venous catheter"
                    },
                    {
                        "text": "CIVAS /CIVA"
                    },
                    {
                        "text": "Central Intravenous Additive Service. Pre-made bags or syringes of medicines supplied \u2018ready to administer' by the pharmacy department"
                    },
                    {
                        "text": "Extravasation"
                    },
                    {
                        "text": "Accidental, inappropriate or inadvertent administration of medication into the subcutaneous or sub-dermal tissues surrounding the administration site"
                    },
                    {
                        "text": "Medusa"
                    },
                    {
                        "text": "Medusa Injectable Medicines Guide \u2013 an online NHS resource accessible free to all staff via the intranet."
                    },
                    {
                        "text": "Midline"
                    },
                    {
                        "text": "A midline catheter is an 8 - 12 cm catheter inserted in the upper arm with the tip located just below the axilla."
                    },
                    {
                        "text": "Paediatrics"
                    },
                    {
                        "text": "Generic term for purpose of this document includes neonates."
                    },
                    {
                        "text": "PGD"
                    },
                    {
                        "text": "Patient Group Direction"
                    },
                    {
                        "text": "Reconstitution"
                    },
                    {
                        "text": "Mixing a powdered drug with a suitable diluent, to allow intravenous medicines administration."
                    },
                    {
                        "text": "TPN"
                    },
                    {
                        "text": "Total Parenteral Nutrition"
                    },
                    {
                        "text": "VIP score"
                    },
                    {
                        "text": "Visual infusion phlebitis score, a method of assessing the cannula site."
                    },
                    {
                        "text": "Wellsky ePMA"
                    },
                    {
                        "text": "The Trust electronic prescribing and medicines administration system used on main inpatient wards."
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Role & responsibilities within the Trust"
            },
            "type": "ListItem",
            "sequence_num": 32
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.1,
                "text": "MSE Quality Governance Group (QGG)"
            },
            "type": "ListItem",
            "sequence_num": 33
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Receiving exception reports and taking action in response to issues raised from Medicines Assurance Group and/or department of pharmacy."
            },
            "type": "ListItem",
            "sequence_num": 34
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.2,
                "text": "MSE Medicines Assurance Group (MAG)"
            },
            "type": "ListItem",
            "sequence_num": 35
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring the effective implementation, use and timely review of this policy;"
            },
            "type": "ListItem",
            "sequence_num": 36
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that monitoring arrangements are appropriately performed by Medicines Optimisation and Safety Group (MOSG);"
            },
            "type": "ListItem",
            "sequence_num": 37
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Where necessary, escalating concerns to the Chief Nurse and site Director of Nursing or Chief Medical Officer and site Medical Directors as appropriate;"
            },
            "type": "ListItem",
            "sequence_num": 38
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Exception reporting to the MSE Quality Governance Group on developments, concerns and progress concerning IV medicines use."
            },
            "type": "ListItem",
            "sequence_num": 39
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.3,
                "text": "MSE Medicines Optimisation and Safety Group (MOSG)"
            },
            "type": "ListItem",
            "sequence_num": 40
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Monitoring this policy through incident reports;"
            },
            "type": "ListItem",
            "sequence_num": 41
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Escalating issues to site divisional governance groups and MAG as appropriate."
            },
            "type": "ListItem",
            "sequence_num": 42
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.4,
                "text": "Chief Executive"
            },
            "type": "ListItem",
            "sequence_num": 43
        },
        {
            "data": {
                "is_heading": 0,
                "text": "As the Trust's accountable officer has overall responsibility for ensuring the Trust has robust, complete and up to date documents in place to govern and guide activities so that legal and national requirements are met."
            },
            "type": "ListItem",
            "sequence_num": 44
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.5,
                "text": "Chief Medical Officer"
            },
            "type": "ListItem",
            "sequence_num": 45
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that there is policy compliance and liaising with the site Medical Directors that the service is operating effectively;"
            },
            "type": "ListItem",
            "sequence_num": 46
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring sufficient resources are in place to implement this policy;"
            },
            "type": "ListItem",
            "sequence_num": 47
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring any escalated IV medication issues involving professions they oversee are appropriately managed corporately."
            },
            "type": "ListItem",
            "sequence_num": 48
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.6,
                "text": "Chief Pharmacist"
            },
            "type": "ListItem",
            "sequence_num": 49
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Setting the overall framework and policy standards for IV medication use across the organisation, in line with regulatory and best practice guidance;"
            },
            "type": "ListItem",
            "sequence_num": 50
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring a monitoring process exists and functions for policy standards."
            },
            "type": "ListItem",
            "sequence_num": 51
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The Chief Pharmacist delegates day-to-day responsibility to the site pharmacy Heads of Department and divisional Principal Pharmacists for delivery."
            },
            "type": "ListItem",
            "sequence_num": 52
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.7,
                "text": "Site and divisional Medical Directors"
            },
            "type": "ListItem",
            "sequence_num": 53
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that there is policy compliance on site by all professions they oversee and that the service is operating effectively;"
            },
            "type": "ListItem",
            "sequence_num": 54
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring any escalated IV medication issues involving professions they oversee are appropriately managed corporately."
            },
            "type": "ListItem",
            "sequence_num": 55
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.8,
                "text": "Chief Nursing Officer"
            },
            "type": "ListItem",
            "sequence_num": 56
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that there is policy compliance and liaising with the Chief & Deputy Chief Pharmacist, site Pharmacy Head/s of Department & MSE Medication Safety Officer that the service is operating effectively;"
            },
            "type": "ListItem",
            "sequence_num": 57
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring sufficient resources are in place to implement this policy;"
            },
            "type": "ListItem",
            "sequence_num": 58
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring any escalated IV medication issues involving professions they oversee are appropriately managed corporately."
            },
            "type": "ListItem",
            "sequence_num": 59
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.9,
                "text": "Site Director of Nursing / Deputy Directors of Nursing / Director of Midwifery"
            },
            "type": "ListItem",
            "sequence_num": 60
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that there is policy compliance on site by all professions they oversee and that the service is operating effectively;"
            },
            "type": "ListItem",
            "sequence_num": 61
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring any escalated IV medication issues involving professions they oversee are appropriately managed corporately;"
            },
            "type": "ListItem",
            "sequence_num": 62
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring sufficient resources are in place to implement this policy."
            },
            "type": "ListItem",
            "sequence_num": 63
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.1,
                "text": "Matron (or Allied Health Professional AHP equivalent) & Ward/Department Manager"
            },
            "type": "ListItem",
            "sequence_num": 64
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring all staff have readily available access to a Trust computer to access essential resources (i.e. Medusa Injectables Guide), at all times;"
            },
            "type": "ListItem",
            "sequence_num": 65
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring all required equipment, devices and sundries are available to staff at all times for safe administration, and taking immediate action (including escalation to senior managers) where this is not the case to ensure safety of IV preparation and administration;"
            },
            "type": "ListItem",
            "sequence_num": 66
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that registered nurses/midwives and other AHPs receive adequate training, support and supervision in the clinical area to complete IV administration competences;"
            },
            "type": "ListItem",
            "sequence_num": 67
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that registered nurses/midwives/AHPs who apply for IV administration training have achieved the expected standards of drug administration, and are signed off as competent prior to IV administration training;"
            },
            "type": "ListItem",
            "sequence_num": 68
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Authorising and removing authorisation (if required) staff to prepare and administer IV medicines;"
            },
            "type": "ListItem",
            "sequence_num": 69
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Determining and communicating to their team, the level of supervision required for Bank or Agency staff working on their ward/department, with respect to the preparation and administration of IV medicines."
            },
            "type": "ListItem",
            "sequence_num": 70
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring compliance with all task they personally perform as an accredited practitioner (see below)"
            },
            "type": "ListItem",
            "sequence_num": 71
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.11,
                "text": "Clinical Nurse Educator/ Practice Education Facilitators responsible for IV administration programme (or equivalent)"
            },
            "type": "ListItem",
            "sequence_num": 72
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Developing clinical competencies and ensuring these remain up to date in line with current best practice guidance;"
            },
            "type": "ListItem",
            "sequence_num": 73
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Facilitating the IV administration programme, and study day/s within;"
            },
            "type": "ListItem",
            "sequence_num": 74
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Facilitating the learning of practical skills within the clinical environment, once theoretical learning has taken place;"
            },
            "type": "ListItem",
            "sequence_num": 75
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Supporting the assessment and monitoring of completion of staff competencies."
            },
            "type": "ListItem",
            "sequence_num": 76
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.12,
                "text": "Registered Accredited Practitioner (i.e. registered nurse/ midwife/AHP with signed off Intravenous medicines administration competencies and completed training)"
            },
            "type": "ListItem",
            "sequence_num": 77
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring they have undertaken, completed and been signed off in writing that they are competent in IV administration within the Trust before they undertake any preparation and/or administration of IV medication;"
            },
            "type": "ListItem",
            "sequence_num": 78
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring they are familiar with the therapeutic uses of the medicines to be administered, it's usual dosing and administration method, side effects, precautions, compatibility, contra-indications and any required management techniques for possible adverse drug reactions that could occur."
            },
            "type": "ListItem",
            "sequence_num": 79
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring preparation and administration is only in line with published recommended guidance such as that documented in this policy;"
            },
            "type": "ListItem",
            "sequence_num": 80
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring all required resources and equipment is available and taking action (including escalating to manager) immediately where this is not the case \u2013 ensuring unsafe preparation and/or administration does not occur;"
            },
            "type": "ListItem",
            "sequence_num": 81
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring they are competent in the safe use and observation of any medical equipment/devices they need to use;"
            },
            "type": "ListItem",
            "sequence_num": 82
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring all preparation of IV medicines is witnessed by a second independent person, where this is required as detailed in this policy;"
            },
            "type": "ListItem",
            "sequence_num": 83
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensures all administration of IV medicines is witnessed by a second independent person at the patient bedside, where this is required as detailed in this policy;"
            },
            "type": "ListItem",
            "sequence_num": 84
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Working within current legislation, within the code of conduct for their professional body, and Trust Administration of Medicines Policy;"
            },
            "type": "ListItem",
            "sequence_num": 85
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Adhering to Evidence based Practice in Infection Control (EPIC) Guidelines."
            },
            "type": "ListItem",
            "sequence_num": 86
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Authority to prepare and administer IV medication"
            },
            "type": "ListItem",
            "sequence_num": 87
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "Any practitioner who is involved in the processes leading to administration of an intravenous medication to a patient is accountable for their actions and their omissions."
            },
            "type": "ListItem",
            "sequence_num": 88
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.2,
                "text": "Intravenous medications may be prepared and administered by an accredited practitioner, or a registered health professional practising under direct supervision of an accredited practitioner, for the purpose of competency achievement."
            },
            "type": "ListItem",
            "sequence_num": 89
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.3,
                "text": "For flushing refer to section 14."
            },
            "type": "ListItem",
            "sequence_num": 90
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.4,
                "text": "Doctors"
            },
            "type": "ListItem",
            "sequence_num": 91
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.4.1 Any medical practitioner (including FY1 doctors) is permitted to prepare and administer intravenous injectable medication independently (except any cytotoxic medication via any route for anti-cancer treatment). Whilst independent checking is permitted, a second independent check by an appropriately competent registrant (as defined by this policy) is accepted good practice where circumstances allow."
            },
            "type": "ListItem",
            "sequence_num": 92
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.4.2 In all cases they are expected to ensure they have the knowledge, skills, and understanding required before undertaking such tasks."
            },
            "type": "ListItem",
            "sequence_num": 93
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.5,
                "text": "Nurses and midwives"
            },
            "type": "ListItem",
            "sequence_num": 94
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.5.1 Registered nurses and midwives may only prepare, administer and monitor peripheral intravenous drugs when they are accredited by the Trust to do so (referred to in this document as \u2018accredited practitioner'). This means they have:"
            },
            "type": "ListItem",
            "sequence_num": 95
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Successfully completed the \u2018IV medication training' (or site equivalent);"
            },
            "type": "ListItem",
            "sequence_num": 96
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Successfully completed and have signed off competency assessments;"
            },
            "type": "ListItem",
            "sequence_num": 97
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Be authorised in writing by Mid & South Essex NHS Foundation Trust to prepare and administer intravenous medicines. In practice this may be a written confirmation from the line manager (or equivalent signing off supervisor)."
            },
            "type": "ListItem",
            "sequence_num": 98
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.5.2 Central line administration of injectable medicines is permissible only after completion of further additional training and local competency assessment. This is outside the scope of this policy."
            },
            "type": "ListItem",
            "sequence_num": 99
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.6,
                "text": "Radiographers"
            },
            "type": "ListItem",
            "sequence_num": 100
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.6.1  Radiographers who have successfully completed the training pack and competency assessment for the preparation, administration and monitoring of peripheral intravenous drugs may administer intravenously as defined by departmental protocol, or otherwise prescribed by a radiologist, medicines required for contrast enhanced radiological procedures. They may also administer intravenously as defined by departmental protocol, or otherwise prescribed by a holder of an ARSAC"
            },
            "type": "ListItem",
            "sequence_num": 101
        },
        {
            "data": {
                "is_heading": 0,
                "text": "certificate specific to the Trust - or someone working under his/her written direction - pre-prepared radio labelled pharmaceuticals and any other medicines required for nuclear medical imaging or therapeutic procedures. Refer to MSEPO-21128 Administration of medicines policy for further details."
            },
            "type": "ListItem",
            "sequence_num": 102
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.7,
                "text": "Pharmacists"
            },
            "type": "ListItem",
            "sequence_num": 103
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.7.1  Pharmacists may perform the calculation check required for preparation of injectable medicines. They may also perform the independent second check of the preparation process."
            },
            "type": "ListItem",
            "sequence_num": 104
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.8,
                "text": "Students (from any healthcare profession group)"
            },
            "type": "ListItem",
            "sequence_num": 105
        },
        {
            "data": {
                "is_heading": 1,
                "text": "5.8.1 Medical and nursing students can participate in the preparation and administration of subcutaneous or intramuscular injections under direct supervision."
            },
            "type": "ListItem",
            "sequence_num": 106
        },
        {
            "data": {
                "is_heading": 1,
                "text": "5.8.2 Students, regardless of professional group, may only observe the administration of intravenous drugs. They may only participate in the preparation of intravenous medicines under direct supervision of a registered accredited practitioner; as a third participant."
            },
            "type": "ListItem",
            "sequence_num": 107
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.8.3 The only exception is student midwives who may administer prescribed intravenous medication on the midwife exemption list under the direct supervision of a registered accredited practitioner acting as sign-off mentor."
            },
            "type": "ListItem",
            "sequence_num": 108
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.9,
                "text": "Trust bank staff"
            },
            "type": "ListItem",
            "sequence_num": 109
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.9.1  Bank staff employed by the Trust are required to adhere to the same requirements to that of permanently-employed Trust staff. The registered nurse/midwife-in- charge must be assured by the competencies of the bank staff member before the shift commences. They must also set out clearly what tasks are permitted to be undertaken by that person before the shift commences."
            },
            "type": "ListItem",
            "sequence_num": 110
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.1,
                "text": "Agency and locum staff (non-Trust employed staff)"
            },
            "type": "ListItem",
            "sequence_num": 111
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.10.1 Agency, or locum staff, who has undergone prior intravenous therapy training can have this recorded on the health roster and checklist done prior to starting a shift for the Trust. The agency or locum staff must present to the nurse/midwife in charge of the clinical area at the beginning of the shift to confirm arrangements. Any issues must be escalated to Matrons immediately."
            },
            "type": "ListItem",
            "sequence_num": 112
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.10.2 The registered nurse/midwife-in-charge must set out clearly what tasks are permitted to be undertaken by that person before the shift commences."
            },
            "type": "ListItem",
            "sequence_num": 113
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.10.3 Agency or locum staff must read this policy and sign to confirm an understanding of this."
            },
            "type": "ListItem",
            "sequence_num": 114
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.10.4 There are no circumstances under which agency or locum staff should be involved in administration of total parenteral nutrition or administration of inotropic drugs outside of a critical care environment."
            },
            "type": "ListItem",
            "sequence_num": 115
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Requirements for single and second-independent checks in adults"
            },
            "type": "ListItem",
            "sequence_num": 116
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.1,
                "text": "This section applies to adult patients only. All paediatric IV medication must be second checked, in all instances."
            },
            "type": "ListItem",
            "sequence_num": 117
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.2,
                "text": "Where possible to do so IV medication should be prepared and checked with two registrants; with the second person being an independent witness to the preparation and administration. However; it is recognised that in order to deliver timely administration (which could cause patient harm if delayed) some IV medication can be safely administered with one registrant, to adult patients only."
            },
            "type": "ListItem",
            "sequence_num": 118
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.3,
                "text": "SINGLE-registrant checks of IV medicines for adult patients only are permitted for the following medicines (if in doubt, undertake a second check in all instances):"
            },
            "type": "ListItem",
            "sequence_num": 119
        },
        {
            "data": {
                "is_heading": 1,
                "text": "6.3.1 Low-risk pre-mixed fluid infusions only:"
            },
            "type": "ListItem",
            "sequence_num": 120
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Pre-mixed Sodium Chloride 0.45% or 0.9% IV infusions WITHOUT potassium;"
            },
            "type": "ListItem",
            "sequence_num": 121
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Glucose 4% or 5% IV infusions WITHOUT potassium;"
            },
            "type": "ListItem",
            "sequence_num": 122
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Sodium Chloride / Glucose combinations WITHOUT potassium;"
            },
            "type": "ListItem",
            "sequence_num": 123
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Hartmann's IV Infusion;"
            },
            "type": "ListItem",
            "sequence_num": 124
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Volplex\u00ae/Gelofusine (Gelatin) IV infusions."
            },
            "type": "ListItem",
            "sequence_num": 125
        },
        {
            "data": {
                "is_heading": 1,
                "text": "6.3.2 Low-risk pre-mixed drug infusions only:"
            },
            "type": "ListItem",
            "sequence_num": 126
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Paracetamol IV infusion;"
            },
            "type": "ListItem",
            "sequence_num": 127
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Phosphate IV infusion;"
            },
            "type": "ListItem",
            "sequence_num": 128
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Bicarbonate IV infusion;"
            },
            "type": "ListItem",
            "sequence_num": 129
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Antibiotic/Antifungal IV infusions in ready-made/ready-to-go form;"
            },
            "type": "ListItem",
            "sequence_num": 130
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Glucose 20% Intravenous Infusion for hypoglycaemia."
            },
            "type": "ListItem",
            "sequence_num": 131
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.3.3 Wellsky ePMA will only prompt for one registrant signature for these medicines. Where paper drug charts are used, one signature is required on the drug chart in the administration box."
            },
            "type": "ListItem",
            "sequence_num": 132
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.4,
                "text": "SECOND-independent registrant checks of IV medicines are required for the following medicines (this list is not exhaustive. If in doubt, undertake a second check in all instances)."
            },
            "type": "ListItem",
            "sequence_num": 133
        },
        {
            "data": {
                "is_heading": 1,
                "text": "6.4.1 ALL medicines requiring manipulation in order to prepare the dose, i.e.:"
            },
            "type": "ListItem",
            "sequence_num": 134
        },
        {
            "data": {
                "is_heading": 0,
                "text": "All medication drawn up and/or reconstituted from vials, ampoules, bottles (unless specifically itemised in section 6.3);"
            },
            "type": "ListItem",
            "sequence_num": 135
        },
        {
            "data": {
                "is_heading": 0,
                "text": "All medication where a drug is added to an infusion bag of fluid;"
            },
            "type": "ListItem",
            "sequence_num": 136
        },
        {
            "data": {
                "is_heading": 0,
                "text": "In practice this IV bolus injections and infusions with additives."
            },
            "type": "ListItem",
            "sequence_num": 137
        },
        {
            "data": {
                "is_heading": 1,
                "text": "6.4.2 ALL High-risk drugs (regardless of whether pre-made or made in the clinical area)"
            },
            "type": "ListItem",
            "sequence_num": 138
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Potassium containing IV Infusions;"
            },
            "type": "ListItem",
            "sequence_num": 139
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Chemotherapy (all routes);"
            },
            "type": "ListItem",
            "sequence_num": 140
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Total Parenteral Nutrition (TPN);"
            },
            "type": "ListItem",
            "sequence_num": 141
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Insulin IV infusions;"
            },
            "type": "ListItem",
            "sequence_num": 142
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Controlled Drugs (all routes);"
            },
            "type": "ListItem",
            "sequence_num": 143
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Heparin containing IV infusions;"
            },
            "type": "ListItem",
            "sequence_num": 144
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Mannitol IV infusion;"
            },
            "type": "ListItem",
            "sequence_num": 145
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Sodium chloride 1.8% and 2.7% IV infusion;"
            },
            "type": "ListItem",
            "sequence_num": 146
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Blood products."
            },
            "type": "ListItem",
            "sequence_num": 147
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.4.3 Requirements of a second independent check are detailed within MSEPO-21128 Administration of medicines policy."
            },
            "type": "ListItem",
            "sequence_num": 148
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.4.4 Wellsky ePMA will only prompt for TWO registrant signatures for these medicines. Where paper drug charts are used, two signatures are required on the drug chart in the administration box."
            },
            "type": "ListItem",
            "sequence_num": 149
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Infection control & waste management"
            },
            "type": "ListItem",
            "sequence_num": 150
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.1,
                "text": "Refer to Trust infection control policies that must be adhered to protect staff and prevent contamination. Key policies are:"
            },
            "type": "ListItem",
            "sequence_num": 151
        },
        {
            "data": {
                "is_heading": 0,
                "text": "MSEPO-20215 Hand Hygiene;"
            },
            "type": "ListItem",
            "sequence_num": 152
        },
        {
            "data": {
                "is_heading": 0,
                "text": "MSEPO-21024 Aseptic non touch technique (ANTT);"
            },
            "type": "ListItem",
            "sequence_num": 153
        },
        {
            "data": {
                "is_heading": 0,
                "text": "MSEPO-21052 Management of needlestick sharps and splash injuries for staff."
            },
            "type": "ListItem",
            "sequence_num": 154
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.2,
                "text": "Gloves and aprons must be discarded after each procedure as \u201corange bag\u201d waste. Refer to MSEPO-21112 Waste Management Policy and Procedure."
            },
            "type": "ListItem",
            "sequence_num": 155
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Requirements before preparation"
            },
            "type": "ListItem",
            "sequence_num": 156
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.1,
                "text": "Access and review the prescription / Patient Group Direction (PGD)"
            },
            "type": "ListItem",
            "sequence_num": 157
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.2,
                "text": "Before beginning preparation, staff must have a prescription/ electronic prescription record or PGD, essential information about the product(s), and processes needed for safe preparation and administration."
            },
            "type": "ListItem",
            "sequence_num": 158
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.3,
                "text": "Always cross-reference between all paper prescription charts and ePMA (where in use). This is essential to ensure administering persons are aware of all prescribed medicines."
            },
            "type": "ListItem",
            "sequence_num": 159
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.4,
                "text": "In the Anaesthetics and Theatres division, an anaesthetic practitioner may prepare items under the direction of an anaesthetist without a prescription or PGD. This will be in line with local departmental protocol, training and competency."
            },
            "type": "ListItem",
            "sequence_num": 160
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.5,
                "text": "Confirm chemical, physical and therapeutic properties & compatibilities"
            },
            "type": "ListItem",
            "sequence_num": 161
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.6,
                "text": "Staff must always prepare and administer medicines in accordance with guidance that is current and approved by the Trust."
            },
            "type": "ListItem",
            "sequence_num": 162
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.7,
                "text": "The approved technical information resource is the electronic NHS Medusa Injectable Medicines Guide (\u2018Medusa'). This is available via the Trust intranet and is freely available to all staff. Managers overseeing clinical areas must ensure all staff preparing medicines have readily available access to a Trust computer workstation for this purpose."
            },
            "type": "ListItem",
            "sequence_num": 163
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.8,
                "text": "Other approved sources include manufacturer's leaflets included within the specific medicine package and current published Trust medication guidelines. Never use a manufacturer leaflet from another brand or box as information may be different, e.g. displacement values can differ between brands. Collation of leaflets in clinical areas is not permitted for this reason."
            },
            "type": "ListItem",
            "sequence_num": 164
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.9,
                "text": "Where information is unclear or further information is required always refer to the pharmacist for advice."
            },
            "type": "ListItem",
            "sequence_num": 165
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "Details to be checked include:"
            },
            "type": "ListItem",
            "sequence_num": 166
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Safe storage, and expiry once prepared;"
            },
            "type": "ListItem",
            "sequence_num": 167
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Suitable diluents for reconstitution;"
            },
            "type": "ListItem",
            "sequence_num": 168
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Suitable infusion solutions and correct flushing solution;"
            },
            "type": "ListItem",
            "sequence_num": 169
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Preparation guidance (i.e. how to prepare to avoid undesirable effects e.g. foaming);"
            },
            "type": "ListItem",
            "sequence_num": 170
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Infusion methods (bolus, infusion etc.);"
            },
            "type": "ListItem",
            "sequence_num": 171
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Rates of infusion;"
            },
            "type": "ListItem",
            "sequence_num": 172
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Compatibility with other drugs/fluids the patient may be receiving;"
            },
            "type": "ListItem",
            "sequence_num": 173
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Monitoring requirements."
            },
            "type": "ListItem",
            "sequence_num": 174
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.11,
                "text": "Calculations"
            },
            "type": "ListItem",
            "sequence_num": 175
        },
        {
            "data": {
                "is_heading": 0,
                "text": "8.11.1  Complex calculations must be documented in the patient health record for future reference. All complex calculations must be checked by a second independent authorised person and second signed to evidence that this has been done."
            },
            "type": "ListItem",
            "sequence_num": 176
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Preparing IV medicines - general principles"
            },
            "type": "ListItem",
            "sequence_num": 177
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.1,
                "text": "Preparation (including reconstitution and addition to infusion bags) and administration of all intravenous medicines must always be an aseptic non touch technique in line with MSEPO-21024 Aseptic non touch technique (ANTT) Policy."
            },
            "type": "ListItem",
            "sequence_num": 178
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.2,
                "text": "All parts of the preparation process must be witnessed by a second independent authorised person, where required, as per this policy (see section 6). Requirements of a second independent check are detailed within MSEPO-21128 Administration of medicines policy."
            },
            "type": "ListItem",
            "sequence_num": 179
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.3,
                "text": "The following medicines are always defined as high risk and must not be manipulated outside of a manufacturing unit (e.g. pharmacy aseptic unit):"
            },
            "type": "ListItem",
            "sequence_num": 180
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Parenteral nutrition: seals may be broken on dual and triple-chamber bags but additions must never be made in wards or departments;"
            },
            "type": "ListItem",
            "sequence_num": 181
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Cytotoxic medicines: will be provided in ready-to-use form."
            },
            "type": "ListItem",
            "sequence_num": 182
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.4,
                "text": "Pre-prepared intravenous medicine bags or syringes should always be used when available, in preference to reconstitution in the clinical area. These are provided by the pharmacy department as part of a central intravenous additive service (CIVAS), or supplied ready-made from the manufacturer, where possible."
            },
            "type": "ListItem",
            "sequence_num": 183
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.5,
                "text": "If more than one IV medicine needs to be prepared, then it must be prepared and administered before another one is made i.e. no batch production should take place. Making up several bags of medicines and placing them in trays is unacceptable. This can, and has, led to incorrect labelling and administration, and risk of patient harm. If a single patient has multiple IV medication due at the same time, then they may all be prepared and administered at that time before moving onto another patient."
            },
            "type": "ListItem",
            "sequence_num": 184
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.6,
                "text": "Prepared injectables must be drawn directly from their original container or ampoules into a syringe and then either administered immediately, or if they are not for immediate use (i.e. preparation for theatre session); the syringe is labelled and checked for later use (see labelling section below). Exceptions to this are in an emergency or an operating theatre, when a registered nurse, registered operating department practitioner or doctor may prepare injections for administration by another doctor, provided that doctor has sight of the original container and is satisfied as to the nature and quantity of the medication."
            },
            "type": "ListItem",
            "sequence_num": 185
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.7,
                "text": "Open systems"
            },
            "type": "ListItem",
            "sequence_num": 186
        },
        {
            "data": {
                "is_heading": 0,
                "text": "9.7.1 Open systems must never be used as a container for injectable medication (including gallipots or other types of open container such as moulded plastic procedure trays). The only permitted exception is for embolization procedures"
            },
            "type": "ListItem",
            "sequence_num": 187
        },
        {
            "data": {
                "is_heading": 0,
                "text": "involving embolic agents that need to be prepared openly. In such a case a clear protocol will exist in the clinical area involved with appropriate training in place."
            },
            "type": "ListItem",
            "sequence_num": 188
        },
        {
            "data": {
                "is_heading": 0,
                "text": "9.7.2 \u2018Open systems' are not acceptable because they risk medication being confused with each other and with other substances (i.e. skin antiseptics). This can and has led to patient harm."
            },
            "type": "ListItem",
            "sequence_num": 189
        },
        {
            "data": {
                "is_heading": 0,
                "text": "9.7.3 \u2018Open systems' can be also contaminated by micro-organisms."
            },
            "type": "ListItem",
            "sequence_num": 190
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.8,
                "text": "Vial use"
            },
            "type": "ListItem",
            "sequence_num": 191
        },
        {
            "data": {
                "is_heading": 0,
                "text": "9.8.1 All vials intended for intravenous use should be treated as single use only and the remainder discarded. Most injectable medicines are licensed for \u201conce-only\u201d use,"
            },
            "type": "ListItem",
            "sequence_num": 192
        },
        {
            "data": {
                "is_heading": 0,
                "text": "9.8.2 Multiple uses of unpreserved injectable medicines are not permitted. Unless the manufacturer's label specifically indicates that the injection contains a preservative, the container must be used to prepare a single dose for a single patient on one occasion only. This includes bags of infusion fluid which must be used once only."
            },
            "type": "ListItem",
            "sequence_num": 193
        },
        {
            "data": {
                "is_heading": 0,
                "text": "9.8.3 Where a medicine contains a preservative, it may only be used for multiple injections in restricted situations. These will be approved and signed off (in writing) as safe and appropriate by the principal pharmacist with divisional responsibility alongside the senior divisional nurse."
            },
            "type": "ListItem",
            "sequence_num": 194
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.9,
                "text": "Reconstitution"
            },
            "type": "ListItem",
            "sequence_num": 195
        },
        {
            "data": {
                "is_heading": 0,
                "text": "9.9.1  All injections must be reconstituted in accordance with guidance / manufacturer instructions. Refer to appendix 1: procedure for reconstitution of injection."
            },
            "type": "ListItem",
            "sequence_num": 196
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.1,
                "text": "Addition of drug to infusion bag"
            },
            "type": "ListItem",
            "sequence_num": 197
        },
        {
            "data": {
                "is_heading": 0,
                "text": "9.10.1 Medication may be added to a commercially available (\u2018proprietary') infusion bag to provide an appropriate strength solution. Refer to appendix 2: procedure for adding medication to IV infusion."
            },
            "type": "ListItem",
            "sequence_num": 198
        },
        {
            "data": {
                "is_heading": 0,
                "text": "9.10.2 The number of additions to the infusion bag via the additive entry port should be minimised."
            },
            "type": "ListItem",
            "sequence_num": 199
        },
        {
            "data": {
                "is_heading": 0,
                "text": "9.10.3 Infusion fluids must not be used to dilute or reconstitute more than one preparation. Decanting spikes must not be used."
            },
            "type": "ListItem",
            "sequence_num": 200
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Maximum fill additions to infusion bags prepared in clinical areas"
            },
            "type": "ListItem",
            "sequence_num": 201
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.1,
                "text": "The table below indicates the maximum fill additions which NHS Pharmaceutical Aseptic Services Group (PASG, 2018a) recommends as guidance to be used by administering staff working in clinical areas without the need to know the specific limits for an individual infusion bag brand."
            },
            "type": "ListItem",
            "sequence_num": 202
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.2,
                "text": "The information in the table below can safely be used for any infusion bag in use in the NHS listed below."
            },
            "type": "ListItem",
            "sequence_num": 203
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Table 1: Maximum fill additions to infusion bags in clinical areas"
            },
            "type": "ListItem",
            "sequence_num": 204
        },
        {
            "type": "table",
            "sequence_num": 205,
            "data": {
                "num_rows": 7,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Bag size / mL"
                    },
                    {
                        "text": "Maximum additional volume to be added to the infusion bag / mL"
                    },
                    {
                        "text": "50"
                    },
                    {
                        "text": "15"
                    },
                    {
                        "text": "100"
                    },
                    {
                        "text": "25"
                    },
                    {
                        "text": "150"
                    },
                    {
                        "text": "25"
                    },
                    {
                        "text": "250"
                    },
                    {
                        "text": "50"
                    },
                    {
                        "text": "500"
                    },
                    {
                        "text": "100"
                    },
                    {
                        "text": "1000"
                    },
                    {
                        "text": "100"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.3,
                "text": "The information in the table can be used for the following infusion container brands:"
            },
            "type": "ListItem",
            "sequence_num": 206
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Baxter Viaflo"
            },
            "type": "ListItem",
            "sequence_num": 207
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Baxter Viaflex"
            },
            "type": "ListItem",
            "sequence_num": 208
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Macopharma Easyflex N"
            },
            "type": "ListItem",
            "sequence_num": 209
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Macopharma Macoflex"
            },
            "type": "ListItem",
            "sequence_num": 210
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Macopharma Macoflex N"
            },
            "type": "ListItem",
            "sequence_num": 211
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Fresenius Freeflex"
            },
            "type": "ListItem",
            "sequence_num": 212
        },
        {
            "data": {
                "is_heading": 0,
                "text": "B Braun Ecoflac"
            },
            "type": "ListItem",
            "sequence_num": 213
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.4,
                "text": "The Trust pharmacy aseptic units have access to detailed information for these containers, and therefore may apply higher fill volumes when compounding aseptically prepared products within the pharmacy aseptic facility."
            },
            "type": "ListItem",
            "sequence_num": 214
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Labelling"
            },
            "type": "ListItem",
            "sequence_num": 215
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.1,
                "text": "Medications must never be stored for even a few minutes without proper labelling."
            },
            "type": "ListItem",
            "sequence_num": 216
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.2,
                "text": "All syringes, including flushes and infusions, must be labelled immediately after preparation by the person who prepared them. \u2018Flag labelling' should be used to make sure that volume graduations on syringes are not obscured. The only exception to these in general clinical areas is where preparation and bolus administration is one uninterrupted process and the unlabelled product does not leave the hands of the person who prepared it."
            },
            "type": "ListItem",
            "sequence_num": 217
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.3,
                "text": "General wards and clinical areas should prepare blank labels as part of the preparation process and attach to the syringe for differentiation of preparations during transportation to the patient. As the purpose of the label here, is simply to identify contents of syringe, that are given immediately after preparation (unlike preparation for infusions), information such as diluents used etc. are not required."
            },
            "type": "ListItem",
            "sequence_num": 218
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.4,
                "text": "A practitioner should never be in possession of more than one unlabelled syringe of medication at any one time."
            },
            "type": "ListItem",
            "sequence_num": 219
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.5,
                "text": "An unlabelled syringe must never be fitted to a syringe pump."
            },
            "type": "ListItem",
            "sequence_num": 220
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 11.6,
                "text": "Infusion labelling"
            },
            "type": "ListItem",
            "sequence_num": 221
        },
        {
            "data": {
                "is_heading": 0,
                "text": "11.6.1 Any intravenous product prepared by adding to an infusion bag must always be fully labelled."
            },
            "type": "ListItem",
            "sequence_num": 222
        },
        {
            "data": {
                "is_heading": 0,
                "text": "11.6.2 Standard \u2018drug additive' labels are available from pharmacy and must always be available in clinical areas giving IV medicines prepared by adding a drug to an infusion bag."
            },
            "type": "ListItem",
            "sequence_num": 223
        },
        {
            "data": {
                "is_heading": 0,
                "text": "11.6.3 A drug additive label must be stuck to the infusion bag and completed with the following minimum information:"
            },
            "type": "ListItem",
            "sequence_num": 224
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Patient name;"
            },
            "type": "ListItem",
            "sequence_num": 225
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Date of preparation;"
            },
            "type": "ListItem",
            "sequence_num": 226
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Time of preparation (addition of the drug to the fluid);"
            },
            "type": "ListItem",
            "sequence_num": 227
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Drug name (the additive);"
            },
            "type": "ListItem",
            "sequence_num": 228
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The concentration (expressed as total mass of drug in total volume of infusion);"
            },
            "type": "ListItem",
            "sequence_num": 229
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Diluent name;"
            },
            "type": "ListItem",
            "sequence_num": 230
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The expiry date and time (once prepared);"
            },
            "type": "ListItem",
            "sequence_num": 231
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Batch number;"
            },
            "type": "ListItem",
            "sequence_num": 232
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The initials of the authorised person preparing;"
            },
            "type": "ListItem",
            "sequence_num": 233
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The initials of the authorised person undertaking the second independent check;"
            },
            "type": "ListItem",
            "sequence_num": 234
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Route of administration;"
            },
            "type": "ListItem",
            "sequence_num": 235
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ward/department name."
            },
            "type": "ListItem",
            "sequence_num": 236
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 11.7,
                "text": "Labelling in critical care, theatre and procedural areas"
            },
            "type": "ListItem",
            "sequence_num": 237
        },
        {
            "data": {
                "is_heading": 0,
                "text": "11.7.1 Critical Care, Theatre, and procedural areas use internationally recognised colour coded systems. Refer to local clinical area protocols for the systems in place."
            },
            "type": "ListItem",
            "sequence_num": 238
        },
        {
            "data": {
                "is_heading": 0,
                "text": "11.7.2 In theatres a scrubbed nurse drawing up and handing a syringe to a surgeon is considered to be undertaking one uninterrupted process. Only one unlabelled medicine must be handled at one time. As intravenous bolus medications are usually given using a flush-medication-flush technique, even when only one intravenous medicine is being administered, the flush must be labelled so that the person administering them does not confuse the flush with the medication."
            },
            "type": "ListItem",
            "sequence_num": 239
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 11.8,
                "text": "Labelling of syringes for use during sterile procedures"
            },
            "type": "ListItem",
            "sequence_num": 240
        },
        {
            "data": {
                "is_heading": 0,
                "text": "11.8.1  In these circumstances a risk assessment should be undertaken by the speciality. If the provision of sterile labels is deemed appropriate, contact the supplies department who will be able to assist with their procurement. If other methods of differentiating prepared injections are used, then a standard operating procedure should be developed and displayed in the area where the activity is undertaken. Such procedures within specialities should be consistent across sites within the Trust."
            },
            "type": "ListItem",
            "sequence_num": 241
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 12.0,
                "text": "Administering IV medicines\u2013 general principles"
            },
            "type": "ListItem",
            "sequence_num": 242
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 12.1,
                "text": "All parts of the administration process must be witnessed by a second independent authorised person, where required, as per this policy (see section 6). This includes all required checks at the bedside. Requirements of a second independent check are detailed within MSEPO-21128 Administration of medicines policy."
            },
            "type": "ListItem",
            "sequence_num": 243
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.2,
                "text": "Ensure an appropriate device for administration is in place (peripheral cannula, midline or central venous catheter (cvc)):"
            },
            "type": "ListItem",
            "sequence_num": 244
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Midlines are peripheral access;"
            },
            "type": "ListItem",
            "sequence_num": 245
        },
        {
            "data": {
                "is_heading": 0,
                "text": "CVCs provide central access and should only be accessed by those trained and deemed competent to do so."
            },
            "type": "ListItem",
            "sequence_num": 246
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.3,
                "text": "The patient's identity must be confirmed (e.g. by the wristband if an inpatient.) An independent check from a second registered practitioner is required for high risk medication in line with section x. Second checking must be in line with the MSEPO- 21128 Administration of medicines policy."
            },
            "type": "ListItem",
            "sequence_num": 247
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.4,
                "text": "Before administering an injection, the following should be available: a current prescription, or a PGD or other written instructions, essential technical information and a prepared and labelled injectable medicine."
            },
            "type": "ListItem",
            "sequence_num": 248
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.5,
                "text": "The patient's cannula site must be checked before giving intravenous medication. If the visual infusion phlebitis (VIP) score (as described in the Trust high impact intervention monitoring tool) is 2 or more the cannula must not be used but removed"
            },
            "type": "ListItem",
            "sequence_num": 249
        },
        {
            "data": {
                "is_heading": 0,
                "text": "and replaced. The VIP score must be documented in the high impact intervention monitoring tool (or equivalent) three times per day."
            },
            "type": "ListItem",
            "sequence_num": 250
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.6,
                "text": "Flush the device for patency (see section 14)."
            },
            "type": "ListItem",
            "sequence_num": 251
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.7,
                "text": "The person administering the medicine and the person witnessing the preparation and administration must personally make a record of administration immediately after the event. This is extremely important in circumstances such as theatres or outpatient clinics where the person administering the injectable may also be the prescriber and there may be no written prescription, or ePMA record."
            },
            "type": "ListItem",
            "sequence_num": 252
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.8,
                "text": "Endorse the drug chart as per MSEPO-21128 Administration of medicines policy and update fluid balance charts as appropriate to record the fluid administered."
            },
            "type": "ListItem",
            "sequence_num": 253
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 24.0,
                "text": "The medication solution (bag / syringe) should be changed as required or replaced every  hours, whichever is soonest. Exceptions to this may be on pharmacy advice or patient controlled analgesia or epidural infusions when the stability of the solution has been established and a closed system is preserved."
            },
            "type": "ListItem",
            "sequence_num": 254
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 13.0,
                "text": "Administration Sets"
            },
            "type": "ListItem",
            "sequence_num": 255
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.1,
                "text": "In all cases the integrity of the packaging must be ascertained before use."
            },
            "type": "ListItem",
            "sequence_num": 256
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.2,
                "text": "An administration set must never be left unsupervised once primed, to avoid the potential for tampering prior to connection to the patient."
            },
            "type": "ListItem",
            "sequence_num": 257
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.3,
                "text": "Recommended maximum times before administration sets shall be changed are:"
            },
            "type": "ListItem",
            "sequence_num": 258
        },
        {
            "data": {
                "is_heading": 0,
                "text": "13.3.1 Continuous Administration Sets: primary and secondary continuous sets shall be changed at least every 72 hours, provided they remain connected. Primary sets which have been disconnected from the patient or secondary sets that have been disconnected from the primary must be discarded."
            },
            "type": "ListItem",
            "sequence_num": 259
        },
        {
            "data": {
                "is_heading": 0,
                "text": "13.3.2 Intermittent Administration Sets: primary intermittent administration sets shall be discarded after each use."
            },
            "type": "ListItem",
            "sequence_num": 260
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 24.0,
                "text": "13.3.3 Parenteral Nutrition, Lipid infusions (i.e. propofol), GTN and Insulin infusions: administration sets must be changed every  hours due to risk of reduced efficacy or contamination. Parenteral nutrition bags must never be re-spiked."
            },
            "type": "ListItem",
            "sequence_num": 261
        },
        {
            "data": {
                "is_heading": 0,
                "text": "13.3.4 Blood and Whole Blood Components: Refer to Blood Transfusion Policy (or equivalent)."
            },
            "type": "ListItem",
            "sequence_num": 262
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.4,
                "text": "There is also the potential risk of bolus effect or incompatibilities with the residual medicine in infusion set, if the same set is subsequently used to administer other infusions. Infusion sets must NOT be continuously used for the administration of different medicine solutions, a new infusion set should be used for each new medicine (NIVAS, 2021). Please also refer to section 14."
            },
            "type": "ListItem",
            "sequence_num": 263
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.5,
                "text": "Administration sets (and any remaining infusion solution) must also be immediately changed:"
            },
            "type": "ListItem",
            "sequence_num": 264
        },
        {
            "data": {
                "is_heading": 0,
                "text": "In all cases where contamination is suspected or the integrity of the product or system has been compromised;"
            },
            "type": "ListItem",
            "sequence_num": 265
        },
        {
            "data": {
                "is_heading": 0,
                "text": "If the vascular device is changed;"
            },
            "type": "ListItem",
            "sequence_num": 266
        },
        {
            "data": {
                "is_heading": 0,
                "text": "If a giving set is disconnected from a patient;"
            },
            "type": "ListItem",
            "sequence_num": 267
        },
        {
            "data": {
                "is_heading": 0,
                "text": "When there is air in the line due to the infusion solution running beyond the drip chamber."
            },
            "type": "ListItem",
            "sequence_num": 268
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.6,
                "text": "Administration sets and unused fluids must be disposed of in accordance with the MSEPO-21112 Waste management policy and procedure immediately after disconnection from the patient."
            },
            "type": "ListItem",
            "sequence_num": 269
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.7,
                "text": "Administration sets must be labelled accurately with date and time to facilitate timely changes. This may be managed through the use of a sticker, or writing in indelible ink on the roller clamp."
            },
            "type": "ListItem",
            "sequence_num": 270
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.8,
                "text": "Administration sets contain an integral air inlet (filtered) for use when infusing solutions in a non-collapsible container. Should this device prove insufficient further venting may be provided using a dedicated air inlet only; which is a single use device and must not be transferred from one container to the next."
            },
            "type": "ListItem",
            "sequence_num": 271
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 14.0,
                "text": "Flushing peripheral cannulae"
            },
            "type": "ListItem",
            "sequence_num": 272
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.1,
                "text": "Peripheral cannulae must be flushed to assess patency and position of the cannula when inserting."
            },
            "type": "ListItem",
            "sequence_num": 273
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.2,
                "text": "Flushing may be undertaken by:"
            },
            "type": "ListItem",
            "sequence_num": 274
        },
        {
            "data": {
                "is_heading": 0,
                "text": "a registered accredited practitioner (trained and assessed as competent);"
            },
            "type": "ListItem",
            "sequence_num": 275
        },
        {
            "data": {
                "is_heading": 0,
                "text": "an authorised trained and assessed competent non-registered healthcare staff;"
            },
            "type": "ListItem",
            "sequence_num": 276
        },
        {
            "data": {
                "is_heading": 0,
                "text": "a student nurse under direct supervision of a registered accredited practitioner."
            },
            "type": "ListItem",
            "sequence_num": 277
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.2.1 Where administered by a competent non-registrant (i.e. healthcare assistant) a pre- filled flush device (rather than an injection ampoule) must always be used. These non-registrants must have undertaken cannulation training and competency to flush a peripheral IV device with 5mls of 0.9% sodium chloride ONLY when inserting a peripheral cannula."
            },
            "type": "ListItem",
            "sequence_num": 278
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.2.2 Non-registered healthcare staff must have:"
            },
            "type": "ListItem",
            "sequence_num": 279
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Successfully completed the IV cannulation study day (or equivalent);"
            },
            "type": "ListItem",
            "sequence_num": 280
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Successfully completed and have signed off competency assessments."
            },
            "type": "ListItem",
            "sequence_num": 281
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.3,
                "text": "Always check for patency before accessing the device. This is required at least once each shift if the device is not in use. If cannula is not in use for 24hrs or more, removal should be considered."
            },
            "type": "ListItem",
            "sequence_num": 282
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.4,
                "text": "A flush must always be prepared with IV medication; flushing is required before and after administration of the medicine."
            },
            "type": "ListItem",
            "sequence_num": 283
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.5,
                "text": "If administration of more than one medication is required at the same time, the cannula must also be flushed in-between each medication to avoid mixing / incompatibility reactions."
            },
            "type": "ListItem",
            "sequence_num": 284
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.6,
                "text": "Flushes must never be left at the bedside for use at the end of an infusion. They must be prepared only as needed."
            },
            "type": "ListItem",
            "sequence_num": 285
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.0,
                "text": "A  ml syringe (or larger) should be used when flushing to assess for position / patency. This avoids excessive pressure which may lead to damage of the device / infiltration / dislodgment of a blockage into the circulation."
            },
            "type": "ListItem",
            "sequence_num": 286
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.8,
                "text": "The volume of the flush may vary according to the size of the patient:"
            },
            "type": "ListItem",
            "sequence_num": 287
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.8.1 For adults a 10ml syringe is recommended, with a volume of 5ml sodium chloride 0.9% for injection."
            },
            "type": "ListItem",
            "sequence_num": 288
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.8.2 For paediatrics a 10ml syringe size is recommended to check patency, but the flush volume will be reduced i.e. 2 - 5ml sodium chloride 0.9% for injection."
            },
            "type": "ListItem",
            "sequence_num": 289
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.8.3 When accessing a midline, a 10ml (standard) or 20ml volume (after blood sampling) is required due to the longer length of the device. For blood sampling refer to Trust blood sampling policy (or equivalent)."
            },
            "type": "ListItem",
            "sequence_num": 290
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.9,
                "text": "Flushing should be undertaken using 0.9% sodium chloride as this is a non-irritant solution and will not cause tissue damage if a problem is identified / infiltration occurs."
            },
            "type": "ListItem",
            "sequence_num": 291
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.1,
                "text": "If sodium chloride 0.9% is incompatible with prescribed infusate, 5% glucose may also be required. The administering person and witness can check this in the manufacturer information leaflet or on NHS Medusa Injectables Guide."
            },
            "type": "ListItem",
            "sequence_num": 292
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.11,
                "text": "Do not use any other flushing solution unless it has been specifically prescribed."
            },
            "type": "ListItem",
            "sequence_num": 293
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 15.0,
                "text": "Flushing after small volume intravenous infusions"
            },
            "type": "ListItem",
            "sequence_num": 294
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 15.1,
                "text": "The National Infusion and Vascular Access Society has published guidance on appropriate line flushing after infusion (NIVAS, 2021). This was prompted by concerns about the theoretical risk of under-dosing in intravenous infusions, when some of the drug is left in the tubing of the giving set at the end of the administration."
            },
            "type": "ListItem",
            "sequence_num": 295
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 15.2,
                "text": "All administering persons should note that this guidance is now included within the Royal Marsden Manual of Clinical Nursing Procedures and is endorsed by the national Injectable Medicines Guide (Medusa) advisory board. Medusa Injectable Medicines Guide monographs have or are being updated to state that intermittent infusions should be flushed to ensure the total dose is given."
            },
            "type": "ListItem",
            "sequence_num": 296
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 15.3,
                "text": "Significance of medicine losses in volumetric pump and gravity infusion sets"
            },
            "type": "ListItem",
            "sequence_num": 297
        },
        {
            "data": {
                "is_heading": 0,
                "text": "15.3.1 The dead space of volumetric pump and gravity infusion sets' is commonly in the range of 20-30mL, but this varies depending on the type and length of the tube. The volume that remains in an infusion set after administration may also vary depending on the type of set and the method of administration (gravity or via pump). The volume of the flush to be administered via the administration set should take account of this."
            },
            "type": "ListItem",
            "sequence_num": 298
        },
        {
            "data": {
                "is_heading": 0,
                "text": "15.3.2 The final volume of the infusion to be administered needs also to be considered. The residual volume is more likely to be clinically significant for small infusions; 100mL and, in particular, 50mL bags."
            },
            "type": "ListItem",
            "sequence_num": 299
        },
        {
            "data": {
                "is_heading": 1,
                "text": "15.3.3 IV infusion sets used to administer large volume, medicine infusions of 250mL or more, or hydration fluids, do not need to be flushed as only a relatively small proportion of medicine will remain in the set."
            },
            "type": "ListItem",
            "sequence_num": 300
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 15.4,
                "text": "Risk of inadvertent bolus administration"
            },
            "type": "ListItem",
            "sequence_num": 301
        },
        {
            "data": {
                "is_heading": 0,
                "text": "15.4.1 To avoid unintended bolus administration of medicine from the dead space in an infusion set, care should be taken to ensure the rate of administration of a flush or subsequent infusion is the same as the rate of administration of the medicine."
            },
            "type": "ListItem",
            "sequence_num": 302
        },
        {
            "data": {
                "is_heading": 0,
                "text": "15.4.2 After completion of an intermittent infusion, an appropriate diluent solution should be administered via the administration set. This is to ensure the full dose of medication has been administered to the patient (Royal Marsden, 2021). The volume of fluid used to flush must take account of patient factors such as fluid restriction."
            },
            "type": "ListItem",
            "sequence_num": 303
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 15.5,
                "text": "Pulsatile push pause flushing technique should be used to finally flush the vascular access device once the infusion set is disconnected."
            },
            "type": "ListItem",
            "sequence_num": 304
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 16.0,
                "text": "Using an infusion pump"
            },
            "type": "ListItem",
            "sequence_num": 305
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 16.1,
                "text": "Always use a pump for all infusions on all neonatal and paediatric patients, and on Adults if available, to avoid under / over infusion."
            },
            "type": "ListItem",
            "sequence_num": 306
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 16.2,
                "text": "Pumps must only be used by registered authorised practitioners that are trained and assessed as competent in their use, or under the direct supervision of a registered authorised practitioner in order to achieve competency."
            },
            "type": "ListItem",
            "sequence_num": 307
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 16.3,
                "text": "TWO registered accredited practitioners are required to be present when setting-up the pump for all high-risk medication that requires two signatures. Both must check the data entry (pump rate etc.) and volume going into the pump independently of each other. This must be done and verified before commencement and if changed."
            },
            "type": "ListItem",
            "sequence_num": 308
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 17.0,
                "text": "Gravity infusions"
            },
            "type": "ListItem",
            "sequence_num": 309
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 17.1,
                "text": "Gravity infusion sets may be used in adults for:"
            },
            "type": "ListItem",
            "sequence_num": 310
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Infusion fluids given alone such as sodium chloride 0.9% or glucose 5% with no added potassium."
            },
            "type": "ListItem",
            "sequence_num": 311
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 17.2,
                "text": "They may be used when all of the following criteria apply:"
            },
            "type": "ListItem",
            "sequence_num": 312
        },
        {
            "data": {
                "is_heading": 1,
                "text": "An infusion pump is not available for infusion fluids with a medicine added where rate of administration does not need to be tightly controlled to prevent adverse effects (SPS, 2021) and gravity administration is possible as defined in national guidance;"
            },
            "type": "ListItem",
            "sequence_num": 313
        },
        {
            "data": {
                "is_heading": 1,
                "text": "AND"
            },
            "type": "ListItem",
            "sequence_num": 314
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Where the drug at that specific dose & strength cannot be safely administered as a bolus dose (in line with national guidance referenced in this document); AND"
            },
            "type": "ListItem",
            "sequence_num": 315
        },
        {
            "data": {
                "is_heading": 0,
                "text": "It is authorised in writing within the Trust by the Chief Nursing Officer / site Director of Nursing in situations where there is a critical shortage of infusion pumps (i.e. pandemic)."
            },
            "type": "ListItem",
            "sequence_num": 316
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 20.0,
                "text": "Refer to appendix 5 for drip rate calculations and Trust guideline MSEGL-21001 for drip rate pre-done calculations for a  drop per mL giving set."
            },
            "type": "ListItem",
            "sequence_num": 317
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 17.4,
                "text": "Practitioners must refer to the relevant national guidance (see references) for gravity infusion administration published by (and freely available online from) :"
            },
            "type": "ListItem",
            "sequence_num": 318
        },
        {
            "data": {
                "is_heading": 0,
                "text": "NHS Specialist Pharmacy Services (SPS);"
            },
            "type": "ListItem",
            "sequence_num": 319
        },
        {
            "data": {
                "is_heading": 0,
                "text": "NHS Medusa Injectables Guide (\u2018Medusa');"
            },
            "type": "ListItem",
            "sequence_num": 320
        },
        {
            "data": {
                "is_heading": 0,
                "text": "National Infusion and Vascular Access Society (NIVAS)."
            },
            "type": "ListItem",
            "sequence_num": 321
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 17.5,
                "text": "The use of any other guidance resources must be approved by the Trust pharmacy department."
            },
            "type": "ListItem",
            "sequence_num": 322
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 18.0,
                "text": "Monitoring of the patient"
            },
            "type": "ListItem",
            "sequence_num": 323
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 18.1,
                "text": "After administration, if possible, ask the patient to report any soreness at the injection site or discomfort of any sort."
            },
            "type": "ListItem",
            "sequence_num": 324
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 18.2,
                "text": "Make a detailed record of administration."
            },
            "type": "ListItem",
            "sequence_num": 325
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 18.3,
                "text": "Re-check the administration site for signs of leakage, infection or inflammation and continue to monitor the patient, contents of the infusion container and the rate of infusion according to local policy."
            },
            "type": "ListItem",
            "sequence_num": 326
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 18.4,
                "text": "Check that the arrangements for monitoring fluid balance or clinical parameters have been made. Ensure that relevant documentation is made available for subsequent regular monitoring to take place."
            },
            "type": "ListItem",
            "sequence_num": 327
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 18.5,
                "text": "Infusions should be monitored to ensure safe administration of prescribed treatment. A minimum standard for active infusions recommends monitoring of the patient, the cannula and infusion site, the administration set, and the infusion pump or device on an hourly basis."
            },
            "type": "ListItem",
            "sequence_num": 328
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 19.0,
                "text": "Extravasation"
            },
            "type": "ListItem",
            "sequence_num": 329
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 19.1,
                "text": "As the signs of extravasations can occur during or after administration this should be considered when an area of inflammation is identified in a patient who has had a venous access device in situ."
            },
            "type": "ListItem",
            "sequence_num": 330
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 19.2,
                "text": "Extravasation should be suspected if one or more of the following are present:"
            },
            "type": "ListItem",
            "sequence_num": 331
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Patient complains of burning, stinging or any discomfort at the vascular access device's injection site;"
            },
            "type": "ListItem",
            "sequence_num": 332
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Resistance is felt when the drug is given as a bolus;"
            },
            "type": "ListItem",
            "sequence_num": 333
        },
        {
            "data": {
                "is_heading": 0,
                "text": "There is an obstruction to flow of fluid when an infusion is in progress;"
            },
            "type": "ListItem",
            "sequence_num": 334
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Swelling or leakage is observed at the injection site."
            },
            "type": "ListItem",
            "sequence_num": 335
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 19.3,
                "text": "Refer to the Trust Extravasation Guidelines (or equivalent)."
            },
            "type": "ListItem",
            "sequence_num": 336
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 20.0,
                "text": "Anaphylaxis"
            },
            "type": "ListItem",
            "sequence_num": 337
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 20.1,
                "text": "Anaphylaxis is a severe, life-threatening generalised or systemic hypersensitivity reaction."
            },
            "type": "ListItem",
            "sequence_num": 338
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 20.2,
                "text": "It is characterised by rapidly developing life-threatening airway and/or breathing and/or circulation problems usually associated with skin or mucosal changes."
            },
            "type": "ListItem",
            "sequence_num": 339
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 20.3,
                "text": "Certain antibiotics, anaesthetic, NSAIDs, aspirin or other drugs have been implicated as triggers."
            },
            "type": "ListItem",
            "sequence_num": 340
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 20.4,
                "text": "Staff should be aware of the signs and symptoms of anaphylaxis and how to access help quickly if required."
            },
            "type": "ListItem",
            "sequence_num": 341
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 20.5,
                "text": "Refer to www.resus.org.uk for further information."
            },
            "type": "ListItem",
            "sequence_num": 342
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 21.0,
                "text": "Training requirements"
            },
            "type": "ListItem",
            "sequence_num": 343
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 21.1,
                "text": "Medical staff are trained and assessed as competent during medical training, they are responsible for ensuring they remain up to date and familiar with Trust equipment."
            },
            "type": "ListItem",
            "sequence_num": 344
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 21.2,
                "text": "All Nurses, Midwives and authorised AHPs undertaking intravenous procedures must be able to provide evidence of relevant training and competency achievement when requested."
            },
            "type": "ListItem",
            "sequence_num": 345
        },
        {
            "data": {
                "is_heading": 0,
                "text": "21.2.1 Intravenous training is provided by the Trust through the Intravenous administration programme (or equivalent). Ward/department managers must only enrol staff on to this course where there is full documented evidence of completed and signed off competencies for general medicines administration already in place."
            },
            "type": "ListItem",
            "sequence_num": 346
        },
        {
            "data": {
                "is_heading": 0,
                "text": "21.2.2 The IV training programme involves an IV study day and mandatory formal competency assessment/s undertaken in clinical practice through Trust-agreed competencies. Pump equipment training is either provided alongside the Trust IV study day or can be booked through the medical equipment team (MEMS or equivalent), depending on the site. Where equipment training has to be booked it is the responsibility of the trainee to contact MEMS to access the training. Training may also be undertaken in the clinical area where an appropriate pump trainer is available. Competencies will be issued and completed in either situation."
            },
            "type": "ListItem",
            "sequence_num": 347
        },
        {
            "data": {
                "is_heading": 0,
                "text": "21.2.3 Full IV accreditation (documented evidence completed and signed-off competencies) must be in place before the registrant is authorised to prepare and/or administer any aspect of IV medication."
            },
            "type": "ListItem",
            "sequence_num": 348
        },
        {
            "data": {
                "is_heading": 0,
                "text": "21.2.4 Registered staff joining from another UK healthcare setting are required to ensure they obtain Trust accreditation for IV medicines preparation and administration. This involves familiarisation with Trust procedures and assessment in line with Trust competencies. In practice this will involve attendance at the IV training sessions and completion of IV competencies. There must be documented evidence provided"
            },
            "type": "ListItem",
            "sequence_num": 349
        },
        {
            "data": {
                "is_heading": 0,
                "text": "of previous training, recent practice and signed off competency assessment/s for intravenous drug administration. Trust-based assessment must include completion and sign-off of intravenous competencies, related medical devices competencies and direct observation of safely preparing & administering drugs; as set out in the competencies."
            },
            "type": "ListItem",
            "sequence_num": 350
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 21.3,
                "text": "Practitioners are responsible for maintaining their competency and must access IV administration sessions where they need to update practice. IV administration training sessions are bookable via the learning management system."
            },
            "type": "ListItem",
            "sequence_num": 351
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 22.0,
                "text": "Monitoring and audit"
            },
            "type": "ListItem",
            "sequence_num": 352
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 22.1,
                "text": "Outlined below is the Trust's process of monitoring compliance with, and the effectiveness of the document's main points."
            },
            "type": "ListItem",
            "sequence_num": 353
        },
        {
            "type": "table",
            "sequence_num": 354,
            "data": {
                "num_rows": 3,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "Aspect of compliance or effectiveness being monitored"
                    },
                    {
                        "text": "Monitoring Method"
                    },
                    {
                        "text": "Individual department responsible for the monitoring"
                    },
                    {
                        "text": "Frequency of the monitoring activity"
                    },
                    {
                        "text": "Group / Committee / forum which will receive the findings/monitoring report"
                    },
                    {
                        "text": "Committee / individual responsible for ensuring the actions are completed"
                    },
                    {
                        "text": "IV study day compliance"
                    },
                    {
                        "text": "Learning management system"
                    },
                    {
                        "text": "Clinical divisions"
                    },
                    {
                        "text": "As required"
                    },
                    {
                        "text": "Quality Governance Group by exception"
                    },
                    {
                        "text": "Divisional governance groups"
                    },
                    {
                        "text": "Correct preparation and administration"
                    },
                    {
                        "text": "Incident reporting system DATIX"
                    },
                    {
                        "text": "Clinical divisions"
                    },
                    {
                        "text": "monthly"
                    },
                    {
                        "text": "site Medicines Optimisation & Safety Group"
                    },
                    {
                        "text": "Medicines Assurance Group"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 23.0,
                "text": "Approval and implementation"
            },
            "type": "ListItem",
            "sequence_num": 355
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 23.1,
                "text": "All policies, procedures and guidelines will be approved by Medicines Assurance Group, which is the specialist group with the authority to approve local medication documents. These will then be forwarded to the Document control team for submission and ratification by the Joint Document Management Group."
            },
            "type": "ListItem",
            "sequence_num": 356
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 23.2,
                "text": "It is the author's responsibility to inform all prescribers, nursing and pharmacy of the approved policy documents when they are uploaded to the Trust's Intranets."
            },
            "type": "ListItem",
            "sequence_num": 357
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 24.0,
                "text": "Equality impact assessment"
            },
            "type": "ListItem",
            "sequence_num": 358
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 24.1,
                "text": "The Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals."
            },
            "type": "ListItem",
            "sequence_num": 359
        },
        {
            "data": {
                "is_heading": 0,
                "text": "(Refer to appendix 6)"
            },
            "type": "ListItem",
            "sequence_num": 360
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 25.0,
                "text": "References"
            },
            "type": "ListItem",
            "sequence_num": 361
        },
        {
            "data": {
                "is_heading": 0,
                "text": "All legacy NPSA alerts are available via the NHS England archive available at https://www.england.nhs.uk/patient-safety/patient-safety-alerts/  Locally held copies are kept by the Trust Medication Safety Officer."
            },
            "type": "ListItem",
            "sequence_num": 362
        },
        {
            "data": {
                "is_heading": 0,
                "text": "National Patient Safety Agency (NPSA) (2007). Patient Safety Alert 20- Promoting Safer Use of Injectable Medicines."
            },
            "type": "ListItem",
            "sequence_num": 363
        },
        {
            "data": {
                "is_heading": 0,
                "text": "National Patient Safety Agency (NPSA) (2016). Patients Safety Alert 8 \u2013 Restricted Use of Open Systems for Injectable Medicines."
            },
            "type": "ListItem",
            "sequence_num": 364
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Neonatal and Paediatric Pharmacists Group (NPPG). (2021) Using bolus IV injections in neonates, children and young people. Online at: http://nppg.org.uk/bolus-iv-injections-in-neonates-children-and-young-people/ [Accessed09.09.2021]"
            },
            "type": "ListItem",
            "sequence_num": 365
        },
        {
            "data": {
                "is_heading": 0,
                "text": "NHS Specialist Pharmacy Service (SPS) (2021). Using gravity infusions and bolus injections in adults Online at: https://www.sps.nhs.uk/articles/using-gravity- infusions-and-bolus-injections-in-adults/  [accessed 09.09.2021]."
            },
            "type": "ListItem",
            "sequence_num": 366
        },
        {
            "data": {
                "is_heading": 0,
                "text": "National Infusion and Vascular Access Society (NIVAS) (2020). COVID19: NIVAS  Gravity infusion and Bolus IV drug administration guidance. Online at:  https://nivas.org.uk/contentimages/main/NIVAS-COVID19-Gravity-Infusion-Bolus- Admin-Giuidance-2-converted-SH.pdf  [accessed 09.09.2021]"
            },
            "type": "ListItem",
            "sequence_num": 367
        },
        {
            "type": "image",
            "sequence_num": 368,
            "data": {
                "url": "MSEPO-21204 MSE Intravenous IV Medicines Policy.003.png"
            }
        },
        {
            "data": {
                "is_heading": 0,
                "text": "National Infusion and Vascular Access Society (NIVAS) (2021). Intravenous Administration of Medicines to adults: Guidance on \u201cline flushing\u201d. Online at: https://nivas.org.uk/contentimages/main/NIVAS-Infusion-flushing-guidelines-2021- Version-3-2-FINAL.pdf [accessed 29.09.2021]"
            },
            "type": "ListItem",
            "sequence_num": 369
        },
        {
            "data": {
                "is_heading": 0,
                "text": "NHS Pharmaceutical Aseptic Services Group (PASG) (2018a). Maximum fill additions to Infusion bags for doses prepared in clinical areas. Online at: https://pasg.nhs.uk/downloads.php?did=493 [accessed 09.09.2021]"
            },
            "type": "ListItem",
            "sequence_num": 370
        },
        {
            "data": {
                "is_heading": 0,
                "text": "NHS Pharmaceutical Aseptic Services Group (PASG) (2018b). Good practice Guidance for Preparing Injections at ward level via syringe-to-syringe mixing. Online at: https://pasg.nhs.uk/downloads.php?did=523 [accessed 09.09.2021]"
            },
            "type": "ListItem",
            "sequence_num": 371
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Royal College of Nursing (RCN) (2016). Standards for Infusion Therapy .Online at: https://www.rcn.org.uk/clinical-topics/infection-prevention-and-control/standards-for- infusion-therapy [accessed 02.08.2021]"
            },
            "type": "ListItem",
            "sequence_num": 372
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The Royal Marsden NHS Foundation Trust (Marsden) (2020). Royal Marsden Manual of Clinical Nursing Procedures Online : Chapter 15 Medicines Optimisation: ensuring quality and safety. Online at: https://www.rmmonline.co.uk/manual/c15- sec-0005 [accessed 29.09.2021]"
            },
            "type": "ListItem",
            "sequence_num": 373
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Royal Pharmaceutical Society and Royal College of Nursing (RPS/RCN) (2019). Professional Guidance on the Administration of Medicines in Healthcare Settings. Online at"
            },
            "type": "ListItem",
            "sequence_num": 374
        },
        {
            "data": {
                "is_heading": 0,
                "text": "https://www.rpharms.com/Portals/0/RPS%20document%20library/Open%20access/ Professional%20standards/SSHM%20and%20Admin/Admin%20of%20Meds%20pr of%20guidance.pdf?ver=2019-01-23-145026-567 [accessed 13.09.2021]"
            },
            "type": "ListItem",
            "sequence_num": 375
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 1: Procedure for reconstitution of an injection"
            },
            "type": "ListItem",
            "sequence_num": 376
        },
        {
            "type": "table",
            "sequence_num": 377,
            "data": {
                "num_rows": 3,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "This procedure requires TWO registrants accredited to prepare & administer intravenous medicines"
                    },
                    {
                        "text": "Both registrants must be present throughout the process of preparation and administration"
                    },
                    {
                        "text": "Second registrant must provide second independent check of the first registrant's process"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 378,
            "data": {
                "num_rows": 7,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Equipment required"
                    },
                    {
                        "text": "Sterile field (following ANTT) Large procedural tray."
                    },
                    {
                        "text": "IV drug (with drug leaflet OR Medusa*)."
                    },
                    {
                        "text": "Sterile intravenous clear syringe of suitable size for each medication, and 10mls intravenous clear syringe (or larger) for flush."
                    },
                    {
                        "text": "Diluent (as identified in drug leaflet / Medusa*) (e.g. Water for injections)."
                    },
                    {
                        "text": "Sterile needles; blunt fill or blunt filter / or blue (as per requirement below)."
                    },
                    {
                        "text": "Compatible solution for flushing (as identified in drug leaflet / Medusa*)."
                    },
                    {
                        "text": "Near point sharps disposal system (tray must be washed prior with detergent / hot water if visibly soiled, cleaned with Universal wipes between patients)."
                    },
                    {
                        "text": "2% chlorhexidine in 70% isopropyl alcohol impregnated moist wipe (e.g. Sani-cloth or Clinell\u00ae wipe)."
                    },
                    {
                        "text": "Wellsky ePMA / Patients drug chart."
                    },
                    {
                        "text": "Sterile white bung (obturator) - for bolus medications."
                    },
                    {
                        "text": "Access to Medusa Injectables Guide* via intranet."
                    },
                    {
                        "text": "Protective clothing: Gloves, non-powdered, latex free."
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensure that the working area is clean and has adequate lighting and space."
            },
            "type": "ListItem",
            "sequence_num": 379
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Pre-checks:"
            },
            "type": "ListItem",
            "sequence_num": 380
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Gather the required equipment and medication."
            },
            "type": "ListItem",
            "sequence_num": 381
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Carry out a second independent check of all medication/s, diluents and flushes with a second registered person, referring directly to the prescription chart, *Medusa injectables guide and drug information leaflet. Check for accuracy, dose, vial integrity and expiry date."
            },
            "type": "ListItem",
            "sequence_num": 382
        },
        {
            "data": {
                "is_heading": 0,
                "text": "CAUTION sound-alike-look-alike medicines \u2013 read drug name in FULL"
            },
            "type": "ListItem",
            "sequence_num": 383
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Undertake all calculations of the dosage BEFORE preparation, taking displacement values into account if a partial dose is to be given. Carry out a second independent check of all calculations with a second registered person."
            },
            "type": "ListItem",
            "sequence_num": 384
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Procedure follows on next page"
            },
            "type": "ListItem",
            "sequence_num": 385
        },
        {
            "type": "table",
            "sequence_num": 386,
            "data": {
                "num_rows": 20,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Action"
                    },
                    {
                        "text": "Rationale"
                    },
                    {
                        "text": "Clear sufficient work area and clean the surface with Universal cleaning wipes. Wash your hands and apply hand sanitiser."
                    },
                    {
                        "text": "Ensures infection control"
                    },
                    {
                        "text": "Open the sterile field to work on, open needles and syringes, white bungs and iv infusion if required, onto sterile field. Retain a syringe packet for use later."
                    },
                    {
                        "text": "If using a large procedural tray ensure this has been decontaminated prior to use; syringes and needles should be assembled prior to placing into tray, in order to protect key parts."
                    },
                    {
                        "text": "Remove the cover from the medication vial, clean the top with a medicated swab, and allow to dry."
                    },
                    {
                        "text": "Open diluent and flush solutions and place outside of sterile field if using."
                    },
                    {
                        "text": "Decontaminate hands and apply gloves."
                    },
                    {
                        "text": "Draw up the flush, using an appropriate needle and taking care not to contaminate the key parts (needle and neck of vial)."
                    },
                    {
                        "text": "ANTT"
                    },
                    {
                        "text": "Without touching the nozzle of the syringe, remove the needle and discard it into a sharps bin."
                    },
                    {
                        "text": "Reinsert the flush into the sterile syringe packaging to protect the key part, and place in the white tray."
                    },
                    {
                        "text": "Draw up the diluent in the same manner, taking care not to contaminate the key parts (needle and nozzle of syringe)."
                    },
                    {
                        "text": "Inject the medication vial with the diluent; for non-vacuumed vials keep the needle above the fluid level, release the syringe plunger to relieve the pressure prior to removing the needle."
                    },
                    {
                        "text": "This prevents spurting."
                    },
                    {
                        "text": "Place the needle and syringe on the sterile field, if using."
                    },
                    {
                        "text": "Avoids possible contamination."
                    },
                    {
                        "text": "Mix the medication according to instruction leaflet, ensuring the injectable part is not touched."
                    },
                    {
                        "text": "-"
                    },
                    {
                        "text": "Once the powder has fully dissolved, draw up the full volume into the syringe. (The fluid may be coloured, but should be clear, unless stated otherwise in the medication leaflet)."
                    },
                    {
                        "text": "Detects incompatibility or degradation that may be unsafe to use"
                    },
                    {
                        "text": "If a partial dose is to be given, ensure the excess is returned / left in the vial for disposal. For antibiotics, when the displacement value is listed in the manufacturers information leaflet, this must be included in the calculations."
                    },
                    {
                        "text": "Helps avoid accidental preparation of wrong dose"
                    },
                    {
                        "text": "Check the volume and dose to be administered with a second registered accredited practitioner."
                    },
                    {
                        "text": "-"
                    },
                    {
                        "text": "The medicine is now prepared for addition to an intravenous solution if further dilution is required."
                    },
                    {
                        "text": "-"
                    },
                    {
                        "text": "If the medication is for bolus administration; discard the needle into a sharps bin, and seal the syringe with a sterile obturator (bung), or reinsert into the sterile packaging."
                    },
                    {
                        "text": "-"
                    },
                    {
                        "text": "Label with medication name, strength, date and time of preparation."
                    },
                    {
                        "text": "Clear identification"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 2: Procedure for adding medication to an IV infusion"
            },
            "type": "ListItem",
            "sequence_num": 387
        },
        {
            "type": "table",
            "sequence_num": 388,
            "data": {
                "num_rows": 3,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "This procedure requires TWO registrants accredited to prepare & administer intravenous medicines"
                    },
                    {
                        "text": "Both registrants must be present throughout the process of preparation and administration"
                    },
                    {
                        "text": "Second registrant must provide second independent check of the first registrant's process"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 389,
            "data": {
                "num_rows": 3,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Equipment required (additional to that required for reconstitution of injection)"
                    },
                    {
                        "text": "Clinically clean receiver or tray."
                    },
                    {
                        "text": "Drug additive label."
                    },
                    {
                        "text": "IV bag of a compatible solution (e.g. 0.9% sodium chloride or 5% Glucose) in the recommended volume and checked for integrity, particles and expiry."
                    },
                    {
                        "text": "Sterile needle if previous needle has been disposed of."
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensure that the working area is clean and has adequate lighting and space."
            },
            "type": "ListItem",
            "sequence_num": 390
        },
        {
            "type": "table",
            "sequence_num": 391,
            "data": {
                "num_rows": 11,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Action"
                    },
                    {
                        "text": "Rationale"
                    },
                    {
                        "text": "Place infusion bag into a clinically clean receiver or tray."
                    },
                    {
                        "text": "Reduces risk of puncturing side of infusion bag"
                    },
                    {
                        "text": "Remove any seal present and decontaminate with a swab. Allow to dry."
                    },
                    {
                        "text": "Ensures infection control"
                    },
                    {
                        "text": "Add the drug immediately on preparation, use a new needle to draw up (as below)."
                    },
                    {
                        "text": "Reduces risk of microbial growth or degradation"
                    },
                    {
                        "text": "Rubber topped vial: use blunt fill needle. Ensure rubber topped vial cleaned with Clinell\u00ae injection wipe (2% Chlorhexidine wipe)."
                    },
                    {
                        "text": "Ensures infection control"
                    },
                    {
                        "text": "Glass ampoule snapped open or glass vial: use blunt fill filter needle. This must be changed for a plain blunt fill before injecting into an infusion bag."
                    },
                    {
                        "text": "Avoids risk of transferring glass shards into the infusion."
                    },
                    {
                        "text": "Taking care not to touch the needle or the port, insert the needle vertically through the injection port of the infusion bag/container/burette and inject the drug."
                    },
                    {
                        "text": "ANTT"
                    },
                    {
                        "text": "Dispose of immediately in a sharps bin. (Do not detach the needle from the syringe)."
                    },
                    {
                        "text": "Avoids needlestick injury"
                    },
                    {
                        "text": "Invert the bag/syringe at least 5 times."
                    },
                    {
                        "text": "Ensures adequate mixing"
                    },
                    {
                        "text": "Check the infusion fluid for any signs of precipitation: haziness, unexpected discoloration and particles. This can occur even if the mixture is theoretically compatible, thus making vigilance essential."
                    },
                    {
                        "text": "Detecting any incompatibility or degradation that may be unsafe to use"
                    },
                    {
                        "text": "Complete a drug additive label (patient details from the prescription chart) with the details of the drug, IV solution and patient details, date, time of addition, route of administration, expiry (date and time) and batch number."
                    },
                    {
                        "text": "Maintain accurate records"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 392,
            "data": {
                "num_rows": 4,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Action"
                    },
                    {
                        "text": "Rationale"
                    },
                    {
                        "text": "Both registrants must sign the drug additive label. The second registrant will have witnessed the entire preparation process and verified is correct."
                    },
                    {
                        "text": "Maintain accurate records"
                    },
                    {
                        "text": "Apply the label to the bag, taking care not to cover the original content information."
                    },
                    {
                        "text": "-"
                    },
                    {
                        "text": "Remove gloves, dispose of all equipment as per Trust policy and wash hands."
                    },
                    {
                        "text": "Ensures infection control"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 393,
            "data": {
                "num_rows": 5,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "If addition is made into a burette at the bedside"
                    },
                    {
                        "text": "avoid contamination of the needle and inlet port;"
                    },
                    {
                        "text": "-"
                    },
                    {
                        "text": "check that the correct quantity of fluid is in the chamber;"
                    },
                    {
                        "text": "Ensures correct dilution"
                    },
                    {
                        "text": "switch the infusion off briefly;"
                    },
                    {
                        "text": "Ensures a bolus injection is not given"
                    },
                    {
                        "text": "add the drug."
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 3: Procedure for administration of IV INFUSION via a PERIPHERAL cannula"
            },
            "type": "ListItem",
            "sequence_num": 394
        },
        {
            "type": "table",
            "sequence_num": 395,
            "data": {
                "num_rows": 3,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "This procedure requires TWO registrants accredited to prepare & administer intravenous medicines (unless the IV is ready-made AND low risk medicine as detailed in this IV policy)"
                    },
                    {
                        "text": "Both registrants must be present throughout the process of preparation and administration"
                    },
                    {
                        "text": "Second registrant must provide second independent check of the first registrant's process"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 396,
            "data": {
                "num_rows": 8,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Equipment required"
                    },
                    {
                        "text": "Clinically clean receiver or tray containing the prescribed infusion to be administered."
                    },
                    {
                        "text": "2% chlorhexidine in 70% isopropyl alcohol impregnated moist wipe (e.g. Sani-cloth, Clinell\u00ae wipe) for cleaning injection site."
                    },
                    {
                        "text": "Wellsky ePMA / Patients drug chart."
                    },
                    {
                        "text": "Compatible solution for flushing."
                    },
                    {
                        "text": "Administration set as appropriate to method of infusion: Gravity flow Via pump e.g.: McKinley syringe pump / Asena GH syringe driver / Alaris GP volumetric or site equivalent."
                    },
                    {
                        "text": "Drug additive label."
                    },
                    {
                        "text": "Protective clothing: Apron / Gloves, non- powdered, latex free."
                    },
                    {
                        "text": "Sharps container."
                    },
                    {
                        "text": "Pump (as required)"
                    },
                    {
                        "text": "Drip stand."
                    },
                    {
                        "text": "Sterile needles and syringes & hypoallergenic tape."
                    },
                    {
                        "text": "Needle free access device if not already in situ."
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 397,
            "data": {
                "num_rows": 9,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Action"
                    },
                    {
                        "text": "Rationale"
                    },
                    {
                        "text": "Before drug reconstitution check on Wellsky ePMA / paper drug chart:"
                    },
                    {
                        "text": "That the medication has not already been administered."
                    },
                    {
                        "text": "Ensures duplicate treatment is avoided"
                    },
                    {
                        "text": "The prescription is CLEAR and confirms the following: Allergy Status Drug, Dose and Route Date and time of administration Diluent (as appropriate) Signature of prescriber"
                    },
                    {
                        "text": "Ensures all required information is available and a legal prescription exists."
                    },
                    {
                        "text": "Ensure patient and site of injection is appropriate:"
                    },
                    {
                        "text": "Check patient identity in accordance with Trust procedure."
                    },
                    {
                        "text": "Ensures correct patient"
                    },
                    {
                        "text": "Explain procedure to patient / parents and allow time for them to ask questions. Check for allergies."
                    },
                    {
                        "text": "Ensures informed consent is obtained"
                    },
                    {
                        "text": "At the bedside, decontaminate hands with hand sanitiser allowing to dry, apply gloves and apron."
                    },
                    {
                        "text": "Ensures infection control"
                    },
                    {
                        "text": "Ensure patient has appropriate peripheral IV cannula access. Assess site using the VIP score system, and check integrity / cleanliness of the dressing. Ascertain as to whether the patient is experiencing any discomfort at the site of insertion which might indicate the peripheral device needs to be re-sited."
                    },
                    {
                        "text": "Ensures IV access is patent / no signs of phlebitis"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 398,
            "data": {
                "num_rows": 17,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Action"
                    },
                    {
                        "text": "Rationale"
                    },
                    {
                        "text": "Preparing and Administering:"
                    },
                    {
                        "text": "Collect equipment together and wash hands, put on gloves and apron."
                    },
                    {
                        "text": "Reduce risk of contamination, minimising infection risk to patient."
                    },
                    {
                        "text": "Prepare medication and dispose of sharps as per policy Second independent check of all preparation undertaken."
                    },
                    {
                        "text": "Ensures medicine has been prepared correctly"
                    },
                    {
                        "text": "At the bedside, decontaminate hands with hand sanitiser and apply gloves and apron."
                    },
                    {
                        "text": "Ensures infection control"
                    },
                    {
                        "text": "Check patient identity in accordance with Trust procedure witnessed by second independent registrant (if required)."
                    },
                    {
                        "text": "Ensures correct patient"
                    },
                    {
                        "text": "Decontaminate the needle free access device with 2% chlorhexidine in 70% isopropyl alcohol and allow to dry."
                    },
                    {
                        "text": "Ensures infection control"
                    },
                    {
                        "text": "Administer flush via needle free access device on cannula. If this is a double connector ensure the other extension is switched off first. Observe site for swelling, leakage and/or patient complaining of pain during the flush."
                    },
                    {
                        "text": "Maintains cannula patency and prevent drug interactions with next infusion."
                    },
                    {
                        "text": "With the second registrant independently checking (if required): Is infusion prepared as prescribed against Wellsky ePMA / Drug chart? Is fluid within expiry date and packaging intact. Agitate the fluid then inspect the fluid. Are their signs of precipitate/inclusions? If so reject solution, do not use. Confirm the correct method of infusion i.e. infusion pump or by gravity. Refer to national guidance and Trust protocols."
                    },
                    {
                        "text": "Ensures medication at the bedside is safe for administration Ensures that infusions are not given inappropriately by gravity, when pump is mandatory."
                    },
                    {
                        "text": "Witnessed by second independent registrant, observing ANTT; insert spike of administration set into the IV bag, then hang IV fluid on drip stand and prime the line (administration set) ensuring no air is present in the line."
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Decontaminate the needle free access device with 2% chlorhexidine in 70% isopropyl alcohol and allow to dry."
                    },
                    {
                        "text": "Ensures infection control"
                    },
                    {
                        "text": "Attach end of administration set securely to cannula via needle free access device. Remove and discard gloves."
                    },
                    {
                        "text": "Ensures infusion will not become detached from cannula."
                    },
                    {
                        "text": "Witnessed by second independent registrant (if required) set at prescribed rate (pump setting or drip rate). Drip rates must be calculated for gravity infusions, and be independently checked by the second registrant."
                    },
                    {
                        "text": "Ensures rate set is correct for the prescription"
                    },
                    {
                        "text": "Administer iv infusion at the recommended rate"
                    },
                    {
                        "text": "-"
                    },
                    {
                        "text": "During administration observe patient for any adverse reactions. Treat accordingly (UK Resus Council Anaphylaxis Algorithm)."
                    },
                    {
                        "text": "-"
                    },
                    {
                        "text": "Secure administration line to patient and label with date of priming. This may be done with a sticker, or writing in indelible ink on the roller clamp."
                    },
                    {
                        "text": "Secures line. Maintain accurate records"
                    },
                    {
                        "text": "Ensure gravity infusions are supported 1 metre or more"
                    },
                    {
                        "text": "-"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 399,
            "data": {
                "num_rows": 6,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "above the cannula site (adults only)."
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Re-check infusion rate/site after 5 minutes. Continue to check fluid administration regularly. Document hourly in paediatrics."
                    },
                    {
                        "text": "Ensures infusion is running as intended"
                    },
                    {
                        "text": "Remove gloves, dispose of all equipment as per Trust policy and wash hands."
                    },
                    {
                        "text": "Avoid injury and cross- contamination from used equipment."
                    },
                    {
                        "text": "Advise the patient / parents to alert a nurse if they feel unwell or have a concern related to their cannula."
                    },
                    {
                        "text": "Ensures prompt action if there is a problem after injection"
                    },
                    {
                        "text": "Both registrants sign drug chart that medicine prepared AND administered with the second registrant (if second person required). Record volume on fluid chart as appropriate. Document in patient health record if any problems with the administration."
                    },
                    {
                        "text": "Maintain accurate records"
                    },
                    {
                        "text": "After completion of an intermittent infusion, an appropriate diluent solution should be administered via the administration set. The volume of fluid used to flush should take into account patient factors such as fluid-restriction."
                    },
                    {
                        "text": "Ensures the full dose of medication has been administered to the patient."
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 400,
            "data": {
                "num_rows": 13,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Process for continuous infusion (after previous infusion given)"
                    },
                    {
                        "text": "Undertake all checks as above."
                    },
                    {
                        "text": "-"
                    },
                    {
                        "text": "Check that the contents of the previous container have been delivered. If not, check that an error has not occurred, and take action to resolve. Inform ward/department manager to confirm appropriate action to take."
                    },
                    {
                        "text": "To ensure that the previous infusion has been administered"
                    },
                    {
                        "text": "Re-apply clean gloves. Switch off the infusion. Hang the new infusion bag on pump stand and then disconnect empty infusion bag."
                    },
                    {
                        "text": "Ensures that the administration spike will not puncture the side wall of the infusion bag"
                    },
                    {
                        "text": "Push the spike in fully without touching the spike and hang the new infusion bag on the infusion stand."
                    },
                    {
                        "text": "Reduces risk of contamination"
                    },
                    {
                        "text": "Re-calculate infusion rate / drip rate."
                    },
                    {
                        "text": "Ensure calculation is correct to deliver drug at correct rate."
                    },
                    {
                        "text": "Re-start the infusion and adjust rate of flow as prescribed"
                    },
                    {
                        "text": "-"
                    },
                    {
                        "text": "If the addition is made into a burette, the infusion can be restarted immediately following mixing and recording and the infusion rate adjusted accordingly."
                    },
                    {
                        "text": "-"
                    },
                    {
                        "text": "Then follow processes as above for:"
                    },
                    {
                        "text": "Observing patient for adverse reactions & treating accordingly"
                    },
                    {
                        "text": "Documentation on the drug chart / fluid charts as appropriate"
                    },
                    {
                        "text": "Discarding of waste correctly"
                    },
                    {
                        "text": "Decontamination of hands"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 4: Procedure for administration of an IV BOLUS injection"
            },
            "type": "ListItem",
            "sequence_num": 401
        },
        {
            "type": "table",
            "sequence_num": 402,
            "data": {
                "num_rows": 3,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "This procedure requires TWO registrants accredited to prepare & administer intravenous medicines"
                    },
                    {
                        "text": "Both registrants must be present throughout the process of preparation and administration"
                    },
                    {
                        "text": "Second registrant must provide second independent check of the first registrant's process"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 403,
            "data": {
                "num_rows": 2,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "This procedure may be carried out via any of the following"
                    },
                    {
                        "text": "The injection or \u2018Y' site of an IV administration set self-sealing needle-less system adaptor attached to a cannula an extension set, multiple adaptor or stopcock (one-, two- or three-way)"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 404,
            "data": {
                "num_rows": 5,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Equipment required"
                    },
                    {
                        "text": "Clinically clean receiver or tray containing the prescribed drug (s) and diluent if required to be administered."
                    },
                    {
                        "text": "2% chlorhexidine in 70% isopropyl alcohol impregnated moist wipe (e.g. Sani-cloth\u00ae, Clinell\u00ae wipe) for cleaning injection site."
                    },
                    {
                        "text": "Patients prescription chart."
                    },
                    {
                        "text": "Compatible solution for flushing."
                    },
                    {
                        "text": "Protective clothing: Apron / Gloves, non- powdered, latex free."
                    },
                    {
                        "text": "Near point sharps disposal system."
                    },
                    {
                        "text": "Sterile needles and syringes & hypoallergenic tape."
                    },
                    {
                        "text": "Sharps container."
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 405,
            "data": {
                "num_rows": 9,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Action"
                    },
                    {
                        "text": "Rationale"
                    },
                    {
                        "text": "Before drug reconstitution check on Wellsky ePMA / paper drug chart:"
                    },
                    {
                        "text": "That the medication has not already been administered."
                    },
                    {
                        "text": "Ensures duplicate treatment is avoided"
                    },
                    {
                        "text": "The prescription is CLEAR and confirms the following: Allergy status Drug, Dose and Route Date and time of administration Signature of prescriber"
                    },
                    {
                        "text": "Ensures all required information is available and a legal prescription exists."
                    },
                    {
                        "text": "Ensure patient and site of injection is appropriate:"
                    },
                    {
                        "text": "Check patient identity in accordance with Trust procedure."
                    },
                    {
                        "text": "Ensures correct patient"
                    },
                    {
                        "text": "Explain procedure to patient / parents and allow time for them to ask questions. Check for allergies."
                    },
                    {
                        "text": "Ensures informed consent is obtained"
                    },
                    {
                        "text": "At the bedside, decontaminate hands with hand sanitiser allowing to dry, apply gloves and apron."
                    },
                    {
                        "text": "Ensures infection control"
                    },
                    {
                        "text": "Ensure patient has IV access. Assess site using the VIP score system, and check integrity / cleanliness of the dressing."
                    },
                    {
                        "text": "Ensures IV access is patent / no signs of phlebitis"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 406,
            "data": {
                "num_rows": 17,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Action"
                    },
                    {
                        "text": "Rationale"
                    },
                    {
                        "text": "Preparing and Administering:"
                    },
                    {
                        "text": "Collect equipment together and wash hands, put on gloves and apron."
                    },
                    {
                        "text": "Reduce risk of contamination, minimising infection risk to patient."
                    },
                    {
                        "text": "Prepare medication and dispose of sharps as per policy. Second independent check of all preparation undertaken."
                    },
                    {
                        "text": "Ensures medicine has been prepared correctly"
                    },
                    {
                        "text": "At the bedside, decontaminate hands with hand sanitiser and apply gloves and apron."
                    },
                    {
                        "text": "Ensures infection control"
                    },
                    {
                        "text": "Check patient identity in accordance with Trust procedure witnessed by second independent registrant."
                    },
                    {
                        "text": "Ensures correct patient"
                    },
                    {
                        "text": "Clean needle free access device with the medicated swab and allow to dry."
                    },
                    {
                        "text": "Ensures infection control"
                    },
                    {
                        "text": "Administer flush (10ml) gently via needle free access device on cannula. If this is a double connector, ensure the other extension is switched off first. (Push and turn the syringe to ten past the hour to connect securely) Observe site for swelling, leakage and/or patient complaining of pain during the flush."
                    },
                    {
                        "text": "Maintains cannula patency and prevent drug interactions with next infusion."
                    },
                    {
                        "text": "Return the flush to the syringe packet."
                    },
                    {
                        "text": "To protect the key part"
                    },
                    {
                        "text": "Witnessed by second independent registrant, observing ANTT, connect the medication syringe in the same manner and administer iv medication at the recommended rate, while continuing to observe for local symptoms at the cannula site."
                    },
                    {
                        "text": "Avoid adverse reactions from giving too fast."
                    },
                    {
                        "text": "During administration observe patient for any adverse reactions. Treat accordingly (UK Resus Council Anaphylaxis Algorithm)."
                    },
                    {
                        "text": "-"
                    },
                    {
                        "text": "If more than one drug is to be administered, flush as before with the compatible flushing fluid between administrations."
                    },
                    {
                        "text": "Prevent drug interactions."
                    },
                    {
                        "text": "Flush again to clear the device of medication, using a push stop method for maximum efficiency."
                    },
                    {
                        "text": "Reduces risk of chemical irritation to the vein"
                    },
                    {
                        "text": "Use positive pressure locking prior to disconnecting the syringe."
                    },
                    {
                        "text": "Reduces risk of blockage"
                    },
                    {
                        "text": "Remove gloves, dispose of all equipment as per Trust policy and wash hands."
                    },
                    {
                        "text": "Avoid injury and cross- contamination from used equipment."
                    },
                    {
                        "text": "Advise the patient / parents to alert a nurse if they feel unwell or have a concern related to their cannula."
                    },
                    {
                        "text": "Ensures prompt action if there is a problem after injection"
                    },
                    {
                        "text": "Both registrants sign drug chart that medicine prepared AND administered with the second registrant. Document in patient health record if any problems with the administration."
                    },
                    {
                        "text": "Maintain accurate records"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 5: Gravity infusion calculations"
            },
            "type": "ListItem",
            "sequence_num": 407
        },
        {
            "type": "table",
            "sequence_num": 408,
            "data": {
                "num_rows": 5,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "CAUTION: Only administer by gravity where this is safe and Where possible ALWAYS use an infusion pump for drug additive infusions."
                    },
                    {
                        "text": "Refer to national guidance to determine if gravity administration is possible,"
                    },
                    {
                        "text": "Administer by gravity as a last resort where a pump is not available and cannot be"
                    },
                    {
                        "text": "obtained."
                    },
                    {
                        "text": "(i.e. insufficient pumps AND authorised by Chief Nursing Officer / Directors of Nursing)."
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Calculating the required drip rate for Gravity flow administration."
            },
            "type": "ListItem",
            "sequence_num": 409
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Check the administration set packaging for drops per mL* (commonly 20)."
            },
            "type": "ListItem",
            "sequence_num": 410
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Take the volume to be given in mLs, and divide by the duration of infusion in minutes."
            },
            "type": "ListItem",
            "sequence_num": 411
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Multiply the answer by the drops per mL on administration set packaging."
            },
            "type": "ListItem",
            "sequence_num": 412
        },
        {
            "data": {
                "is_heading": 0,
                "text": "This gives you drops per minute; open the roller clamp and count the drops, adjusting the roller clamp until you have the correct rate."
            },
            "type": "ListItem",
            "sequence_num": 413
        },
        {
            "type": "table",
            "sequence_num": 414,
            "data": {
                "num_rows": 3,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "For giving sets with 20 drops per mL use the Trust guideline which has drops/min"
                    },
                    {
                        "text": "pre-calculated to avoid calculation errors:"
                    },
                    {
                        "text": "Click here for MSEGL-21001: IV Infusions: mLs per hour vs. drops per minute"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 415,
            "data": {
                "num_rows": 5,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Calculation:"
                    },
                    {
                        "text": "drops/min = volume of solution (mL) x number of drops per mL* Time (mins) Volume (mL) X Drops per mL* Time (hours) 60"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "This is 1000 divided by 8 hrs = 125mls per hour, divided by 60 mins = 2.08 mLs /min 2.8 x 20 drops per mL = 41.6 drops / min, so in practice this is 42 drops/min."
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Peripheral intravenous (IV) medicines administration policy / MSEPO-21204/ 1.0"
            },
            "type": "ListItem",
            "sequence_num": 416
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 44.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 417
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Peripheral intravenous (IV) medicines administration policy / MSEPO-21204/ 1.0"
            },
            "type": "ListItem",
            "sequence_num": 418
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix6: Preliminary Equality Analysis"
            },
            "type": "ListItem",
            "sequence_num": 419
        },
        {
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to Peripheral intravenous (IV) medicines administration policy: (Please tick all that apply)"
            },
            "type": "ListItem",
            "sequence_num": 420
        },
        {
            "type": "table",
            "sequence_num": 421,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "\u2610 A change in a service to patients"
                    },
                    {
                        "text": "\u2610 A change to an existing document"
                    },
                    {
                        "text": "\u2610 A change to the way staff work"
                    },
                    {
                        "text": "\u2612 A new document"
                    },
                    {
                        "text": "\u2610 Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 422,
            "data": {
                "num_rows": 7,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "1."
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "Harmonised for MSE-wide use"
                    },
                    {
                        "text": "2."
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "Consistently described practice across all sites"
                    },
                    {
                        "text": "3."
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "Patients and staff from consistent expectations"
                    },
                    {
                        "text": "4."
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No \u2013 no changes to requirements only providing clarity"
                    },
                    {
                        "text": "5."
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change?"
                    },
                    {
                        "text": "Yes"
                    },
                    {
                        "text": "b) If so, with whom?"
                    },
                    {
                        "text": "See page 1 & 2"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 423,
            "data": {
                "num_rows": 2,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Preliminary analysis completed by:"
                    },
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Richard Ketley"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "Principal Pharmacist Medication Safety"
                    },
                    {
                        "text": "28 September 2021"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 41.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 424
        }
    ]
}